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Candida yeasts are common commensals that can cause mucosal disease and life-
threatening systemic infections. While many of the components required for defense against 
Candida albicans infection are well established, questions remain about how various host cells 
at mucosal sites assess threats and coordinate defenses to prevent normally commensal 
organisms from becoming pathogenic. Using two Candida species, C. albicans and C. 
parapsilosis, which differ in their abilities to damage epithelial tissues, we used traditional 
methods (pathogen CFU, host survival, and host cytokine expression) combined with high-
resolution intravital imaging of transparent zebrafish larvae to illuminate host-pathogen 
interactions at the cellular level in the complex environment of a mucosal infection. In zebrafish, 
C. albicans grows as both yeast and epithelium-damaging filaments, activates the NF-kB 
pathway, evokes proinflammatory cytokines, and causes the recruitment of phagocytic immune 
cells. On the other hand, C. parapsilosis remains in yeast morphology and elicits the recruitment 
of phagocytes without inducing inflammation. High-resolution mapping of phagocyte-Candida 
interactions at the infection site revealed that neutrophils and macrophages attack both Candida 
species, regardless of the cytokine environment. Time-lapse monitoring of single-cell gene 
expression in transgenic reporter zebrafish revealed a partitioning of the immune response 
during C. albicans infection: the transcription factor NF-kB is activated largely in cells of the 
  
swimbladder epithelium, while the proinflammatory cytokine tumor necrosis factor alpha (TNF-a) 
is expressed in motile cells, mainly macrophages. Our results point to different host strategies 
for combatting pathogenic Candida species and separate signaling roles for host cell types.   
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CHAPTER 1 
1.INTRODUCTION AND BACKGROUND 
1.1 Host-Pathogen Interactions 
We live in a microbe-rich world. Our skin and mucosal surfaces are constantly in contact 
with micro-organisms: those present in the environmental and those that make their home on us 
– commensal microbes. Our mucosal tissues, in cooperation with our immune system, must 
tolerate beneficial microbes while also protecting us from disease-causing organisms. In this 
chapter, I will discuss important aspects of this delicate balancing act. 
1.1.1 Human microbiota 
We are surrounded by microbes. The number of microbe species is estimated to be 
between several million and a trillion (1–4). Estimates of microbial abundance suggest there are 
over 1,000 bacterial phyla, one to five million fungal species worldwide and up to 120,000 
species of microfungi in the U.S. alone (5). Microbes have colonized every habitat imaginable, 
including humans. We play host to a microbiome that encompasses three kingdoms and 
matches us in cell numbers (6). The species that make up our microbiome vary from person to 
person and in different environments in the body (5). The content of our microbiome fluctuates, 
depending on our age, state of health, our diet, and other factors. Commensal organisms help 
us; they provide digestive enzymes, synthesize essential nutrients, and prevent our being 
colonized by more harmful organisms. Our microbiome contributes to the development of 
immunity, influences our digestion, cancer risk and even mental health (7–9). The mycobiota 
(fungal microbiome) has been an overlooked part of the mucosal microbiome but that is being 
rectified (10). Given their numbers, diversity and influence, it’s vitally important that we 
understand our interactions with commensal organisms.  
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1.1.2 Commensalism vs. disease  
By definition, a commensal organism does its host no harm. Microbes that damage their 
hosts are designated as pathogens. However, it’s important to understand that a particular 
microbe cannot always be categorized definitively as a commensal or a pathogen (11). A 
microbe can reside commensally until a change in host biology allows disease to occur. 
Additionally, the damage inherent in disease can result from an overzealous host immune 
response as well as from microbial action. Thus, disease needs to be understood in the context 
of the interactions between host and microbe.  
Although the organisms of our microbiota are usually good guests, many do cause 
disease. The switch from commensalism to pathogenicity is connected to changes in the 
makeup of our microbiome and to changes in host immune function. Our challenge as hosts is 
to respond appropriately to the organisms of our microbiome, tolerating them as commensals 
but mounting a defense against them when they threaten us as pathogens. 
1.1.3 Detecting and responding to disease  
Traditionally, we have understood the role of our immune system to be the recognition 
and response to threats in the form of “foreign” microbes. In the case of disease-causing 
organisms not usually found on or in our bodies, recognition, leading to attack and elimination of 
the microbe, is a good protection strategy. However, in the case of our microbiome, beneficial 
organisms must be tolerated, our immune system must be prevented from excess activity that 
could damage our own tissues, and commensal microbes must be kept from growing 
uncontrolled (12). This demands a complex balancing act, and yet, in healthy humans, this 
balance is achieved by our barrier tissues and our immune system. The following section will 
explore their roles in detail.  
1.2 Host Defenses 
Although I am not a violent person, I sometimes find it useful to think of host defenses at 
mucosal tissues using a military analogy. While epithelial tissue acts as a wall to keep out 
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intruders (pathogens), the cells of these barriers also act as look-outs, sounding the alarm when 
the wall comes under attack. Receiving these messages are the soldiers (immune cells) that 
respond to defend the barriers from attack by pathogens. This section will summarize the roles 
of these barriers and their defenders.  
1.2.1 Barriers  
The epithelial tissues form the barrier wall between the interior of our bodies and the 
external environment. Our skin’s outermost layer is a keratinized stratified epithelium that forms 
a tough, waterproof barrier to invasion. Although we think of our respiratory, digestive and 
reproductive tracts as internal, they must remain open to the external environment in order to 
facilitate gas exchange, nutrient intake, elimination and reproduction (13). These tissues are 
lined with mucosal epithelium and mucus serves a protective function. In the fight against 
invading microbes, epithelial cells were once thought to serve only as barriers, but it’s now 
known that they play key signaling roles in initiating and coordinating immune responses. 
1.2.2 Innate immunity 
If the cells of the skin and mucosal tissues can be thought of as the watchers on the 
wall, their calls for help are received by the soldiers, the cells of the innate immune system. 
Innate immune cells include mast cells, natural killer cells, eosinophils, basophils, and the 
phagocytic cells: neutrophils, macrophages and dendritic cells. These cells detect the presence 
of pathogen associated molecular patterns (PAMPs) using germ line encoded pattern 
recognition receptors (PRRs). Innate immune cells do not have memory in the classical sense. 
Their roles include phagocytosis and killing of pathogens, signaling to amplify immune 
responses and recruit more phagocytes, and presentation of antigens to the cells of the 
adaptive immune system.  
1.2.3 Adaptive immunity  
The adaptive immune system is capable of memory and of specific recognition of 
pathogens. Adaptive cells involved in protection at barrier tissues include T cells, B cells, and 
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dendritic cells. The combined efforts of the innate and adaptive immune systems work to keep 
pathogens in check. Human pathogens have evolved in tandem with our immune system so 
have many strategies to counter its efforts. 
1.3 Fungal Pathogens 
When defending against attack, it is important for the army to know the enemy. The 
enemy in question is a fungal pathogen of the genus Candida. This section will introduce fungal 
pathogens and describe the pathogenic Candida species and the illnesses they cause.  
Of the approximately five million fungal species on earth, only 0.01% are able to cause 
disease in humans (14). Because the human immune system and fungal commensals have co-
evolved, commensal fungi generally do not infect people unless there is an underlying problem 
with the immune system. Fungal disease is on the rise, mainly due to medical advances that 
save lives but have led to increasing populations of immunocompromised patients.  
To be a pathogen of a human host, fungi need to be able to do 4 things: grow at human 
body temperatures, get past external barriers, lyse human tissue to gain nutrients, and resist 
immune defenses (14). Fungi from only 4 of the many fungal lineages are able to infect humans, 
even when we are immunocompromised. They are the Zygomycota, Entomophthorales, 
Ascomycota and Basidiomycota. For the purposes of this literature review, I will split the 
pathogenic fungi into two categories, those that are generally found outside the human body but 
can enter and sometimes cause disease (environmental fungi), and those whose natural 
environment is the human body (commensal or parasitic fungi). This group includes the Candida 
species, the subjects of this dissertation, and I will describe their characteristics and the 
diseases they cause in detail. 
1.3.1 Environmental fungi 
Fungi are important recyclers, degrading dead plant and animal tissue to obtain nutrition. 
Some fungi can cause disease in immunocompromised patients even though their normal 
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environment is not the human body. Two examples illustrate the variety of infection mechanisms 
fungi employ. 
Aspergillus fumigatus (Ascomycota) is a ubiquitous, soil-dwelling saprophyte whose 
spores enter the air and are breathed into the lungs by the thousands. In healthy humans 
Aspergillus is managed by resident immune cells and no disease symptoms arise. However, in 
immunocompromised hosts, the spores germinate and grow in filamentous form, invade lung 
tissue, grow into and along blood vessels, block blood flow, and cause necrotizing pneumonia. 
Aspergillus is capable of dissemination through the blood to the brain, eyes and kidneys. It 
affects patients with mutations in NADPH oxidase (Chronic Granulomatous Disease) and those 
being treated with iatrogenic immunosuppression (15).  
Cryptococcus spp. (Basidiomycota) are environmental saprophytes (organisms that live 
on dead or decaying matter). The two species that infect humans are C. neoformans and C. 
gattii. C. gattii is one of the few fungal species that is able to cause disease in apparently 
immunocompetent hosts. Dried yeast are inhaled, can cause pneumonia and often disseminate. 
In healthy hosts Cryptococcus can survive dormant in the lung or other organs for years and 
then reactivate when immune defenses are suppressed. In immunocompromised patients it 
often breaches the blood-brain barrier to cause meningoencephalitis, which is fatal if untreated 
(14, 16) 
1.3.2 Commensal fungi 
Candida species (Ascomycota) are the most common human commensal and 
pathogenic fungi. There are 15 Candida species that cause disease but only five cause 90% of 
infections: C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, and C. krusei (17). Infection by 
Candida takes on two forms; mucosal infection occurs in people with defects in adaptive 
immunity while disseminated infection is connected with hospital environment and dysfunctional 
innate immune cells, especially neutrophils.  
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1.3.3 Candida disease states 
Candida species colonize the mucosal surfaces of the human digestive, respiratory, and 
(female) reproductive tracts. Their pathogenic potential lies in their ability to shift from harmless 
colonization to overgrowth on superficial tissues, leading to invasion into deeper tissues, then 
potentially to dissemination through the blood stream to internal organs (18, 19). Candida 
species are the 4th most common cause of nosocomial bloodstream infection in the U.S. with a 
mortality rate of around 50% (20). Candida spp. are responsible for several forms of superficial 
disease on skin and mucosal surfaces. Because mucosal candidiasis is the focus of this 
dissertation, these diseases will be discussed in more detail.  
1.3.3.1 Chronic mucocutaneous candidiasis  
Chronic mucocutaneous candidiasis (CMC) is a “recurrent or persistent infection 
affecting nails, skin and oral or genital mucosae” (21). CMC occurs in individuals with inherited 
or acquired T-cell deficiencies, for example: auto-immune deficiency syndrome (AIDS), 
autosomal dominant Hyper IgE syndrome (HIES), STAT1 gain-of-function mutations, 
deficiencies in IL-12 receptor  b1, IL-12p40, CARD9, RORgT, autoimmune polyendocrinopathy 
candidiasis-ectodermal dystrophy (APECED), and mutations in interleukin (IL)-17 pathway 
components such as IL-17 receptor (R)A, IL-17RC, ACT1, and the cytokine IL-17 (Soltész et al., 
2013, Conti and Gaffen, 2015).  
1.3.3.2 Oropharyngeal candidiasis 
Oropharyngeal candidiasis (OPC) is an infection of the tongue and oral mucosa that 
manifests as white, curd-like patches (pseudomembranous candidiasis, aka thrush) or reddened 
patches (erythematous candidiasis) (18, 23–26). Oral lesions cause discomfort and difficulty 
chewing and swallowing. OPC is often the first manifestation of HIV/AIDs infection and up to 
90% of HIV patients will get OPC at some point. OPC is common in infants and young children, 
before their adaptive immunity develops, and in people using dentures, corticosteroid inhalers, 
cigarettes, broad-spectrum antibiotics, and immunosuppressive and chemotherapeutic drugs, 
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those with diabetes and transplant recipients. OPC is one form of candidiasis seen in patients 
with CMC. 
1.3.3.3 Vulvovaginal candidiasis  
Vulvovaginal Candidiasis (VVC) is an infection of the genital mucosa in 
immunocompetent women, usually by C. albicans, although other Candida species have been 
isolated from affected and asymptomatic individuals (27, 28). Symptoms include severe itching, 
pain, redness, vaginal discharge and painful intercourse. Predisposing factors include the use of 
oral contraceptives or broad-spectrum antibiotics, pregnancy, and diabetes. VVC is common 
enough that 75% or more of women of childbearing age will have at least one episode and 
around 9% have recurrent infection (RVVC). Treatment with antifungal drugs is generally 
effective and recurrence is prevented by removing the predisposing factor(s). It’s thought that C. 
albicans’ ability to switch from the yeast to hyphal morphology is largely responsible for the 
occurrence of VVC in healthy women with no genetic predisposition for other forms of 
Candidiasis (29). Recruitment of neutrophils to the vaginal mucosa does not clear the fungus 
but instead, exacerbates symptoms (30). 
1.3.3.4 Dermal candidiasis 
Fungi are part of the skin microbiota but can be pathogenic under certain circumstances. 
Fungal skin infections plague around 20-25% of people worldwide and other skin conditions 
such as psoriasis and atopic dermatitis have connections to Candida colonization (31). Dermal 
Candidiasis is one manifestation of CMC and as such, has some susceptibility factors in 
common with VVC and OPC. 
1.3.4 Candida albicans 
C. albicans is the most common cause of both mucosal and disseminated Candidiasis 
and, thus, is the most thoroughly studied of the Candida species. As an obligate commensal of 
mammals, it co-evolved with its hosts, and is perfectly adapted to its commensal lifestyle. 75% 
of humans carry Candida albicans and a healthy immune system keeps Candida in its 
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commensal mucosal niche (32). As in other fungal infections, disfunctions in the immune system 
are usually a factor in pathogenesis. C. albicans is one of only two Candida pathogens that are 
able to form true hyphae. Hyphae are capable of damaging epithelial tissues in vitro and much 
has been made of the role of hyphae in disease (33). Morphotype switching and epithelial 
damage are factors in C. albicans ability to disseminate from the gut to the blood-stream (34, 
35). 
1.3.5 Non-albicans Candida species 
Although C. albicans is the most common cause of candidiasis in humans, several non-
albicans Candida (NAC) species are also clinically relevant and their isolation from bloodstream 
infections has been increasing over time (36). The Candida species are a polyphyletic group 
(derived from more than one common ancestor), placed in the same genus due to common 
characteristics (37). Of the species most commonly isolated from patients, C. albicans, C. 
tropicalis, C. parapsilosis, and C. dubliniensis are closely related while C. glabrata is a distant 
cousin, closer to the bread yeast Saccharomyces cerevisiae. The Candida species have 
different geographic distributions: C. albicans and C. glabrata are the most commonly isolated 
species in Europe and North America while C. tropicalis is the most prevalent species in India 
and Latin America (38). The patient populations at risk of infection by each species also differ. 
For example, C. glabrata causes thrush in the elderly and denture-wearers and C. dubliniensis 
is most often responsible for thrush in HIV/AIDs patients. 
The Candida species are generally polymorphic; most grow in yeast and pseudohyphal 
forms but only C. albicans and C. dubliniensis form true hyphae (37). Interestingly, C. 
dubliniensis is much less virulent that C. albicans, an indication that hyphal growth is only one of 
many traits contributing to virulence. Host phagocytes and epithelial cells respond differently to 
the different Candida species and much remains to be discovered in this area. Studying the 
mechanisms behind these differences could yield important information to guide our attempts to 
counter these pathogens (Miramón, Kasper and Hube, 2013; Whibley and Gaffen, 2015).  
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A recently arisen fungal pathogen, Candida auris, is causing a global public health threat 
in the form of serious outbreaks of invasive Candidiasis in health care settings (39, 40). C. auris 
was first described in 2009 in Japan and genetic analysis has shown that four separate clades 
arose simultaneously in different regions around the world. Difficulties in combatting this 
pathogen stem from problems with identifying it, its ability to form persistent biofilms on medical 
devices and its resistance to antifungal agents. Because it was only recently discovered, 
relatively little is known about C. auris interactions with host cells. In a zebrafish model and in 
coincubation with human neutrophils, recruitment, phagocytosis, killing and the formation of 
NETs were all reduced against C. auris in comparison to C. albicans (41). It’s ability to avoid 
neutrophil detection and attack may contribute to its pathogenicity. However, more work is 
needed on interactions between host immunity and this threatening Candida species. 
1.3.6 Candida parapsilosis 
C. parapsilosis is the second (or third, depending on geographic location) most common 
Candida species isolated from patients with invasive candidiasis (42, 43). Its incidence in the 
hospital setting is on the rise, although it’s geographic and patient population profiles differ from 
those of C. albicans. It disproportionately affects premature infants and unlike C. albicans, which 
is passed vertically from mother to infant during vaginal birth, C. parapsilosis was shown to 
originate mainly from exogenous sources such as hand carriage on caregivers. (34, 43, 44). C. 
parapsilosis also infects adult patients with indwelling devices, central venous catheters, 
prosthetics, and those receiving total parenteral nutrition, an indication of its ability to form 
persistent biofilms. Although C. parapsilosis is a commensal on the skin and in the gut, blood-
stream isolates usually don’t match gut or skin isolates but, instead, often match isolates found 
on catheters. Because of the serious health threats pose by C. parapsilosis, several labs have 
made it their focus of study in recent years. 
  
  10 
1.4 Virulence Factors 
Gene knock-out studies have elucidated the importance of many virulence traits of C. 
albicans, including adhesins, secreted aspartyl proteinases (SAPs), lipases, and the ability to 
form true hyphae (33, 45–47). These studies have tested the effects of various C. albicans 
knock-out strains in vitro in epithelial and immune cell models and in vivo in mouse, rat, and 
recently, in zebrafish models. The discovery of virulence traits in C. parapsilosis lags behind C. 
albicans. However, C. parapsilosis also adheres to and invades epithelial cells in vitro, and 
causes illness in mouse and rat models (48–51). C. parapsilosis is unable to form true hyphae 
but its lipases and SAPs are important to its ability to damage host cells and cause disease (51–
54). Our current knowledge of the virulence traits of these two Candida species will be 
summarized.  
1.4.1 Immune evasion 
C. albicans uses several strategies to avoid detection by the immune system and to 
counter immune attack (55–57). Epitope masking is one strategy to avoid detection. The cell 
wall polysaccharide b-glucan is an important PAMP for recognition of C. albicans by the Dectin-
1 receptor, but it is mostly hidden under a layer of mannoprotein. b-glucan is unmasked during 
infection in a process involving neutrophil NET-mediated attack and the C. albicans response to 
attack: cell wall remodeling that exposes b-glucan.  
C. albicans avoids phagocytosis by secreting SAPs, which degrade complement, and 
Pra1, a complement inhibitor. SAPs 9 & 10 are also able to cleave histatin, a host antimicrobial 
peptide (13). Inside phagocytes, C. albicans catalase and superoxide dismutase counteract 
killing by host reactive oxygen species (ROS) (13). Secreted lipases allow Candida to take 
advantage of lipids in the host and also alter host immune responses by converting host 
arachidonic acid to prostaglandins (58–60). Neonates in intensive care are given lipid-rich 
parenteral nutrition and this may help to explain the why C. parapsilosis, with its complement of 
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lipases, seems particularly suited to infect this population (51). An excellent body of work has 
shown that C. parapsilosis lipases contribute to biofilm formation, suppression of immune 
signaling, virulence and survival in phagocytes (reviewed in (Toth et al., 2017)).  
C. albicans and C. parapsilosis are able to survive in macrophages and, in vitro, can 
initiate filamentous growth and kill the host (62, 63). In vivo, however, macrophages and C. 
albicans reach a stand-off, with the yeast surviving and replicating but not able to germinate 
(64). Survival within phagocytes can lead to dissemination from mucosal sites through the blood 
stream to organs of the body. Potentially aiding in dissemination, C. albicans and C. 
parapsilosis are able to prevent phagosome maturation and escape from macrophages through 
nonlytic extrusion (vomocytosis) (63, 65, 66). 
1.4.2 Dissemination 
To cause systemic disease, Candida species must breach barriers and gain access to 
normally sterile areas of the body (67–69). Skin and mucosal colonization can serve as a 
reservoir for Candida, from which it may invade. In the hospital setting, mechanical breach of 
barriers through injury, surgery or insertion of intravenous catheters is likely to provide a route of 
entry for Candida into the blood stream. However, several host- and pathogen-directed 
mechanisms have also been proposed to account for Candida dissemination.  
Host inflammatory response to infection initiates the production of chemokines and 
cytokines which lead to a number of responses including vasodilation, edema and the 
recruitment of phagocytes to the site of infection. Thus, passive travel of yeast through gaps in 
tissue left by extravasating phagocytes is one possible route of entry into the blood stream (70). 
Phagocytes engulf Candida at the site of infection and carry it by reverse migration back to the 
blood stream. They may then act as “Trojan Horses”, traveling in the blood flow to other parts of 
the body where they release their cargo. Release of viable Candida by macrophages occurs 
both by pyroptotic or necrotic lysis and by non-lytic exocytosis (66, 71, 72). A third mechanism, 
transcytosis, was suggested by the ability of hyphae and yeast to induce endocytosis of into 
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endothelial cells. Subsequent exocytosis into the lumen of blood vessels could allow 
dissemination (Sheppard and Filler, 2015, Grubb, et al 2008). Evidence from the zebrafish 
model indicates that phagocyte-dependent and -independent mechanisms are both at play in 
dissemination in vivo (Scherer et al., manuscript in preparation).  
1.4.3 Morphogenesis 
Candida species are pleiomorphic; able to form yeast, pseudohyphae, true hyphae and 
chlamydospores, and their ability to switch between morphologies is an essential virulence trait 
(14, 73, 74). Yeast reproduce by budding and remain unicellular, pseudohyphae are oblong 
cells that remain attached in chains, while the hypha is a tube-shaped, mycelial growing form. In 
addition to these morphologies, Candida yeast also differentiate into at least two recognized 
phenotypes (white and opaque) and others have recently been reported (75–77). C. 
parapsilosis adopts the yeast and pseudohyphal form in nature and during infection but does 
not form true hyphae.  
In mucosal candidiasis, the hyphal form is the most damaging and therefore thought of 
as the pathogenic form of C. albicans, whereas the yeast are thought to be commensal at 
mucosal sites (29, 33). Experiments using epithelial cells in culture and reconstituted human 
tissue (RHT) models have shown that hyphae are better able than yeast to invade and damage 
epithelial tissues (78, 79). Hyphae grow directionally and use mechanical force to penetrate 
tissue but also have other weapons (80). The yeast to hyphal transition is accompanied by 
changes in expression of a variety of virulence-related genes. Hyphae upregulate adhesin 
genes (HWP 1&2, ALS3, RBT1, HYR1), certain secreted aspartyl proteinases (SAPs 4-6), and 
ECE1, one product of which is the recently discovered peptide, Candidalysin, that causes 
damage by forming pores in epithelial cells (46, 81). Hyphal expression of adhesins enables 
invasion by endocytosis into epithelial and endothelial cells (82, 83). Adhesins similar to those in 
C. albicans are found on C. parapsilosis pseudohyphae (84, 85) 
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Candida morphology affects its interactions with immune cells. Phagocytes are less able 
to ingest and kill C. albicans hyphal forms, presumably because of their size and shape, but 
differential gene expression may also play a role (63). However, in C. parapsilosis, the size and 
orientation of pseudohyphae do not affect phagocytosis. Macrophages in vitro prefer to ingest 
yeast rather than hyphae and Candida species are able to undergo the switch to filamentous 
growth within macrophages C. albicans hyphal growth within macrophages killing the host cell 
(86). Evidence from intravital imaging in the zebrafish indicates that C. albicans yeast are 
incapable of switching to hyphae in macrophages but are able to replicate in yeast form(64). In 
addition to their differential ability to cause disease in mucosal settings, yeast and hyphal forms 
also play different roles in dissemination of Candida disease, as recently demonstrated by 
Seman and colleagues in the zebrafish (74).   
1.4.4 Adhesion  
The yeast form of Candida is probably the first to adhere to uncolonized surfaces, 
followed by the formation of hyphae and/or pseudohyphae with their greater adherence ability 
(79). Adhesins include the Als family of proteins and Hwp1. Als 1-4 are expressed specifically 
by the hyphal form of C. albicans. Als3 binds to E-cadherin on epithelial cells and N-cadherin on 
endothelial cells (82).  
Adhesive properties of C. parapsilosis clinical isolates were linked to their virulence in a 
buccal epithelial cell model (87). One adhesin gene, Cpar2_404800, has been identified and 
tested in buccal epithelial cells and a mouse model of urinary tract infection (84). Another, the 
product of gene CpAls7, was found to be effective in providing adhesion to extracellular matrix 
proteins (85, 88) 
1.4.5 Invasion  
Candida albicans invades epithelial tissues by two mechanisms: active penetration and 
induced endocytosis (89). Induced endocytosis has been recorded and intensively studied in 
vitro (and recently observed in vivo in the zebrafish – Scherer, et al, in prep) (89–91). In the 
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stratified squamous epithelial tissues on which C. albicans normally resides, however, active 
penetration of the outer layers of non-proliferative, inactive cells must occur before the fungus 
can be endocytosed by the active cells of the lower layers. Receptor-Induced Endocytosis (RIE) 
is a host-driven, actin-dependent, clathrin-mediated process. Live and killed Candida are 
endocytosed equally well and hyphae are more readily endocytosed than yeast. Invasins in the 
Candida cell wall, upregulated in the yeast to hyphal switch (e.g. Als3, Ssa1), interact with host 
cell receptors to initiate the process. Receptors include the receptor tyrosine kinases Egfr and 
Her2, E-cadherin on epithelial cells, and N-cadherin on endothelial cells (92). Active penetration 
is Candida-driven, requiring fungal factors including turgor pressure, growth of the hyphal tip 
and secretion of host tissue-damaging enzymes such as SAP2 and SAP5 (93, 94). 
1.4.6 Damage 
Intriguingly, invasion of tissue and the ensuing damage appear to be somewhat 
mechanistically separate events. Penetration of hyphae is required for significant damage to 
occur – non-hyphal species and yeast locked mutants do much less damage to epithelial tissue 
in vitro and are less virulent in vivo (95). Endocytosed cells are capable of causing damage but 
the process of endocytosis itself is not damaging, as endocytosis of dead C. albicans causes no 
damage (96). Sustained hyphal growth is required for damage to occur, as evidence by the D/D 
EED1 mutant, which invades tissue but then reverts to pseudohyphal/yeast growth and causes 
little tissue damage (78). Invasion brings Candida into close contact with living cells of the 
epithelial layer where secreted molecules (i.e. SAPs, lipases, phospholipases and the peptide 
Candidalysin) could more efficiently damage them.  
Candida is also capable of manipulating host cell death pathways. C. albicans induces 
apoptosis in macrophages, neutrophils and epithelial cells (97–100). However, epithelial cells, in 
co-cultures with C. albicans, limit apoptotic pathways and the eventual cause of epithelial cell 
death is necrosis. The relative contribution of various damage mechanisms to disease 
progression in vivo is an exciting avenue for future study. 
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1.4.7 Biofilm formation 
Biofilm formation on implanted medical devices, such as vascular and urinary catheters 
and dentures, can lead to systemic infection and therefore poses significant health risks. A 
biofilm is a three-dimensional structure formed by microbes on biotic and abiotic surfaces. 
Mucosal candidiasis is essentially the formation of biofilms on mucosal tissues (101–103). 
Candida biofilms begin with cell wall-mediated adherence of fungi. The yeasts proliferate to form 
a thin layer and as the biofilm matures, pseudohyphal and/or hyphal growth commences. 
Biofilms mature as extracellular matrix (ECM) material is secreted and accumulates around and 
between the fungal cells. In the dispersal stage, yeast are budded off from the biofilm to travel to 
new sites of colonization.  
Biofilm formation contributes to the virulence of Candida species. Biofilms are resistant 
to mechanical and other stresses and to attacks from the host immune system. Candida in 
biofilms are less susceptible to antifungal drugs because of their slower growth rate, the 
protection offered by the impermeable ECM surrounding the cells, the upregulation of efflux 
pumps, and the development of dormant persister cells. Perhaps due to changes in gene 
expression and epigenetics, yeast dispersing from biofilms are more virulent than those from the 
same isolates grown in suspension (103, 104).   
C. albicans biofilms are highly structured, containing yeast, pseudohyphae, hyphae, and 
dormant, highly drug-resistant persister cells, all encased in a thick ECM of proteins, 
glycoproteins, carbohydrates, lipids and nucleic acids (103, 105). C. parapsilosis biofilms are 
thinner and less structured, contain both yeast and pseudohyphae, and have an ECM with a 
higher carbohydrate and lower protein content. A network of genes contributes to C. albicans 
biofilm formation. The network includes 6 master transcriptional regulators (Bcr1, Tec1, Efg1, 
Ndt80, Rob1 and Brg1) which bind to the promoters of ~1,000 genes (106). Although fewer 
studies have addressed the genetics of C. parapsilosis biofilm formation, homologues for 
transcription factors Efg1 and Bcr1 and Als-like adhesin proteins play a role, as do the lipase 
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genes CpLIP1 and CpLIP2 (54, 105, 107, 108). Because biofilm formation on catheters and 
indwelling devises are closely linked to cases of deadly systemic candidiasis, host cell 
interactions with Candida biofilms is an active area of study. 
1.5 Host Mucosal Immune Defenses   
Mucosal tissue is a complex environment made up of many cell types. Epithelial cells 
and their associated extracellular matrix form physical barriers Epithelial layers are supported by 
mesenchymal tissue containing fibroblasts. Blood vessels, lined with endothelial cells, bring 
cells of the innate and adaptive immune system that migrate in an out of the mucosal layers. 
Mucosal tissues are patrolled by resident immune cells, mainly macrophages. Each cell type 
has a role to play in the battle against pathogens and communication between cells is essential 
to their success in battle.  
Unlike systemic Candida infection, which is associated with defects in innate immune 
cells, mucosal candidiasis occurs in people with defects in adaptive immunity. Therefore, I will 
discuss adaptive immune involvement in mucosal candidiasis first. However, the development 
of adaptive immunity depends on cells and signals of the innate immune system. Epithelial cells 
and cells of the innate immune system encounter Candida at the mucosa and recognize and 
signal about the infection, respond immediately, and carry out effective clearance at the 
direction of the adaptive immune system, so I will dedicate most of this section to their roles. 
1.5.1 Mucosal adaptive immunity  
The mucosal surfaces of healthy people are often colonized with Candida; thus, most 
people develop adaptive immunity to Candida as children. The importance of adaptive immunity 
in control of mucosal Candidiasis became apparent early in the HIV/AIDS epidemic since OPC 
is often the first indication that a patient has AIDS (109). This led to the realization that CD4+ (T 
helper) cells were essential in preventing mucosal candidiasis. The importance of Th1 immunity 
in fighting fungal infections is well-established in humans and in murine models. Th2 immunity is 
detrimental in most fungal infections because it dampens the immune response through the 
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production of anti-inflammatory cytokines. Whereas earlier work focused on Th1/Th2 balance, 
it’s now known that the more recently-discovered Th17 cell subset is a primary player in 
protection from both mucocutaneous and systemic candidiasis. In fact, defects in any gene 
component of the IL-17 signaling pathway (IL-17RA, IL-17RC, Act1) predispose patients to oral 
candidiasis.  
Development of adaptive immunity begins with activities of the innate immune system. 
PRRs on antigen-presenting cells (i.e. macrophages, dendritic cells) recognize three unique 
fungal PAMPS: chitin, glucans (a and b) and mannans (109, 110). Recognition leads to 
phagocytosis, then degradation of the pathogen and presentation of antigen to naïve T-cells. 
Binding of these PAMPs initiates a signaling cascade leading to the induction of major 
histocompatibility complex (MHCs), co-stimulatory molecules and cytokines, which in turn leads 
to the induction of adaptive immunity via Th1 and Th17 differentiation Th17 immunity is induced 
when IL-1b, TGF-b and IL-6 prime CD4+ T cell precursors to differentiate into Th17 cells, while 
IL-23 maintains and expands them.  
Th-17 cells produce cytokines IL-17A, IL-17F, IL-21, IL-22, and GM-CSF (Conti & 
Gaffen, 2015). GM-CSF is a chemokine that stimulates maturation of neutrophils in the bone 
marrow. IL-17A/F homo- and hetero-dimers are detected by the IL-17 receptor, a dimer of IL-
17RA and IL-17RC. Signaling proceeds through ACT1 and TRAF6 to activate transcription 
factors NF-kB, C/EBP and MAPK. IL-17 is thought to be detected mainly by non-hematopoietic 
cells where it induces the production of cytokines and anti-microbial peptides (111, 112). In 
mucosal Candidiasis, IL-17 acts on keratinocytes and epithelial cells to produce antimicrobial 
molecules such as S100A, b-defensins, and histatins.  
Regulatory T cells have dual roles (110). They dampen immune responses through 
production of IL-10, TGF-b and IL-35 and they repress IL-12 release so reduce Th1 
differentiation. Tilting the balance towards Th17 and away from regulatory T (Treg) cells 
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increases immunity to C. albicans while TNF-a antagonists, often used to treat inflammatory 
disease, promote Treg development and increase the risk of fungal disease. Treg cells also 
have positive functions with respect to fighting fungal infection. They are able to promote 
immune memory by shaping the response to the pathogen and they promote Th17 
differentiation through sequestration of IL-2.  
Humoral immunity targets antigens in the fungal cells wall:  b-glucan and ALS3 in C. 
albicans (110). Immunoglobulins attack fungi in two ways: directly, by killing or inhibiting growth 
of fungi, and indirectly, by enhancing the microbicidal activity of effector cells through 
opsonization and activation of complement leading to phagocytosis or by antibody-directed cell 
toxicity leading to lysis of fungal cells. Vaccination against Candida could provide AIDS patients 
with immunity that doesn’t rely on CD4+ T cells and antibody therapies could be helpful to those 
who are immunocompromised in this arm of the immune system.  
Activation of adaptive immunity is required for resolution of mucosal fungal infections. 
The transition from innate to adaptive depends on antigen-presenting cells and on cytokines 
and chemokines produced by cells of the innate immune system. I will introduce the activities of 
the innate branch of immunity in the next section. 
1.5.2 Mucosal innate immunity  
Innate immune cells found in mucosal tissues include macrophages, dendritic cells, 
neutrophils and innate lymphoid cells. In addition, epithelial cells function in many ways as non-
professional immune cells in their signaling and the production of secreted defenses against 
pathogens. These host cells carry PRRs that recognize Candida ligands then induce protective 
measures including phagocytosis, killing, and cytokine production which amplifies innate 
immune responses and also leads to the development of adaptive immunity. 
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1.5.2.1 Host receptors to recognize Candida 
PRRs are germ-line encoded transmembrane proteins whose ligands include a wide 
variety of PAMPs (113–115). PRRs recognize three unique fungal pathogen-associated 
PAMPS: chitin, glucans and mannans. Host cells detect Candida through classical PRRs such 
as the toll-like receptors (TLRs) and C-type lectin receptors (CLRs), and also through 
interactions between Candida cell wall proteins and several non-canonical receptors on 
epithelial cells.  
The TLRs 2, 4, and 6 recognize fungal cell wall carbohydrates phospholipomannan, O-
linked mannans, and zymosan, respectively (116). Intracellular receptors TLR7 and 9 recognize 
fungal RNA and DNA, respectively (68). Polymorphisms in TLR genes are linked to human 
susceptibility to fungal infections in situations involving immunosuppression (117–120). The 
importance of TLR signaling in Candida infection is somewhat disputed since mice deficient in 
the TLR adaptor, MyD88, are susceptible to infection by several fungal species while their 
human counterparts are not (121). In spite of this, several instances of cooperative signaling 
between TLRs and other receptors exist (122). 
CLRs are the most important class of receptors for fungal recognition. They mediate 
fungal binding and phagocytosis, induction of antifungal effector mechanisms and production of 
cytokines, chemokines, and inflammatory lipids (113). The CLRs which detect Candida 
components include Dectin1, Dectin2, Mannose Receptor, Mincle, and DC-Sign. Mannose 
Receptor (MR) on macrophages recognizes branched N-bound mannans from C. albicans. 
Short, straight, O-linked mannans are recognized by TLR4 (123, 124). Different immune cell 
types recognize Candida species using different receptors; on dendritic cells (DCs), the receptor 
DC-sign joins MR in detection of C. albicans mannans (116). Dectin-2 may also detect mannans 
but it must interact with Fc(g) receptor in order to signal.  
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Dectin-1 is a CLR that binds to b-glucan which makes up 60% of the C. albicans cell wall 
(125). b-glucan is hidden under a layer of mannan but is exposed at bud scars and when 
Candida is under immune attack (55, 56). Human studies reveal that Dectin-1 is required for 
defense against CMC and VVC but not disseminated Candidiasis (126, 127).  
Synergy and overlap between different receptors could be one reason for the lack of a 
susceptible phenotype in humans with polymorphisms in certain receptor genes. Galectin 
(GAL)3 and TLR2 cooperate to discriminate C. albicans from a non-infectious fungus (116). Cell 
wall component Chitin is recognized by TLR9, NOD2 and MR and stimulation produces an anti-
inflammatory IL-10 response (128). Dectin-1 and TLR2 signaling cooperate to produce the 
protective IL-17 response to C. albicans through prostaglandin E2 and macrophages require co-
stimulation of TLR2 and Dectin-1 to produce pro-inflammatory cytokine, TNF-a (129). 
1.5.2.2 Signaling pathways 
PRRs signal to initiate defensive mechanisms including phagocytosis, respiratory burst, 
and expression of genes involved in the inflammatory immune response and in directing the 
development of adaptive immunity (68, 126, 130–133). The CLRs use spleen tyrosine kinase 
(SYK) adaptor and signaling requires an immunoreceptor tyrosine-based activation motif 
(ITAM), either as part of the intracellular portion of the receptor itself, or, in the case of Dectin-2 
and Mincle, in an adapter protein like FcRg. ITAMs are phosphorylated by src-family kinases 
leading to activation of SYK. In the case of Dectin-1, binding to b-1,3-glucans in the fungal cell 
wall initiates SYK activation. SYK then activates the CARD9-Bcl10-MALT1 complex which leads 
to NF-kB activation and production of cytokines and chemokines including TNF, IL-2, IL-10, 
CXCL2, IL-1b, IL-6, and IL-23. Dectin-2 and Mincle also signal via CARD9-Bcl10_MALT1 and 
cytokine transcription occurs through ERK, p38 and MAP kinases. Caspase recruitment domain 
(CARD) 9 is required to link Dectin1/Syk to Bcl10-Malt1-dependent NF-kB activation. CARD9-
deficient mice are much more susceptible to systemic C. albicans infection and CARD9 
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mutation in humans is associated with susceptibility to both systemic and mucosal fungal 
infections.  
Signaling and the output of signaling cascades in response to C. albicans differs in 
different host cell types. This is partially due to the complement of PRRs expressed by different 
cell types. Signaling patterns in individual cell types (macrophages, neutrophils and epithelial 
cells) will be detailed in the following sections.  
1.5.2.3 Epithelial cells 
While many details of myeloid cell detection of Candida have been determined, much 
less is known about how Candida is detected by the cells that make up epithelial tissues. When 
stimulated with live, heat-killed or UV-killed yeast or hyphae of C. albicans, epithelial cells in 
culture produce cytokines including IL-8, GM-CSF, IL1a, IL-6, IFNg, TNFa (80, 99). However, 
detection of Candida in epithelial cells doesn’t depend on TLR2, TLR4, MR or Dectin-1, which 
are used by phagocytes to detect Candida (99).  
Results are not always in agreement on the role of Candida morphology in its detection 
by epithelial cells. In one study, cytokine production by epithelial cells was found to depend on 
the dose of Candida but not on the hyphal morphology (99). In another study, however, hyphal 
and non-hyphal Candida species strains could activate NF-kB and MAPK-cJun but this 
activation didn’t lead to cytokine production (134). Hyphae were required to activate the second 
phase of epithelial cells response which involved MKP1-cFos activation, and induced cytokine 
release (135). Later work implicated PI3K signaling which leads to responses that protect 
epithelial cells from damage, including suppression of apoptosis (136). Since the time of those 
studies, the discovery of Candidalysin, a hypha-specific, secreted, peptide toxin has provided a 
mechanism for the activation of the second phase of signaling (81, 137). Candidalysin acts by 
creating pores in epithelial cells, inducing calcium influx, and activating of the AP-1 transcription 
factor c-Fos via the ERK1/2, MKP1, MAPK signaling pathway (81). Candidalysin is key to 
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virulence traits in both oral and vaginal murine in vivo models and human cell culture models 
(138).  
In addition to cytokines that mediate phagocyte recruitment, epithelial cells attack 
pathogens directly by secreting defensive molecules including annexin A1, S100 alarmins, and 
the antimicrobial peptides b-defensin and cathelicidin (LL-37) in response to Candida infection 
(80, 139, 140). 
1.5.2.4 Neutrophils 
Neutrophils are myeloid-derived innate immune effector cells. They are characterized by 
their granules and their multi-lobed nuclei. Neutrophils are the dominant cell type in early 
response to infection and injury (141). Their job is to identify, engulf and kill pathogen cells. 
However, neutrophil activation is implicated in non-specific tissue damage and development of 
inflammatory diseases, autoimmunity, and ischemia-reperfusion injuries, so their responses 
need to be well-regulated.  
Neutrophils play a role in fighting both mucosal and systemic Candidiasis. They were 
found to block filament invasion in zebrafish mucosal infection (142). Neutrophils are recruited 
to mucosal sites of infection by cytokines released by epithelial cells, innate lymphoid cells and 
tissue resident macrophages. During inflammatory responses, production of granulocyte 
macrophage colony stimulating factor (GM-CSF) ensures that hematopoiesis will provide a 
supply of replacement neutrophils.  
Weapons in the neutrophil arsenal include phagocytosis and subsequent killing, release 
of granules, and production of neutrophil extracellular traps (NETs) (143). Phagocytosis 
depends on recognition of cell-wall components. Neutrophils recognize and phagocytose 
Candida by at least two different mechanisms: one is opsonin and Fcg receptor-dependent and 
the second is opsonin-independent but depends on the lectin-binding site of complement 
receptor (CR)3. Once Candida is engulfed, the phagosome fuses with lysosomes and granules, 
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exposing Candida to a deadly cocktail of low pH, reactive oxygen species (ROS), reactive 
nitrogen species (RNS), proteases, and antimicrobial peptides. Neutrophil granules containing 
cytotoxic proteins and peptides aid in attacking fungi when they fuse with phagosomes or when 
released extracellularly during degranulation. NETs are a mesh of chromatin threads decorated 
with histones, proteases, and antimicrobial peptides (144). NETs bind to microbes and have 
been implicated in killing them. Evidence indicates that NETs cause damage C. albicans 
hyphae in vitro and in vivo (142, 145, 146).  
Given their extensive repertoire of anti-fungal mechanisms, it should not be surprising 
that neutrophils respond differently to different Candida species. Neutrophils phagocytose and 
damage C. parapsilosis more efficiently than C. albicans (147, 148). Even though C. 
parapsilosis has more exposed b-glucan in the cell wall, its phagocytosis doesn’t depend on  b-
glucan detection by Dectin-1 while phagocytosis of C. albicans is reduced in neutrophils treated 
with a Dectin-1 antibody. Likewise, different mechanisms of attack are employed against the 
different Candida morphologies(149). Soluble lectin receptor, Gal3, enhanced phagocytosis of 
C. parapsilosis yeast and C. albicans hyphae, but not C. albicans yeast. When encountering 
hyphae that are too large to ingest, neutrophils make contact, wrap around them and attack by 
secreting ROS and releasing NETs (55, 142, 150, 151). Extracellular release of ROS may serve 
as a mechanism for transmitting information about microbe size: higher ROS levels are tied to 
signaling that recruits more neutrophils to large hyphal forms that are difficult to ingest (152). 
Understanding the variety of interactions between neutrophils and different Candida species 
may help us to better treat patients with Candidiasis. 
1.5.2.5 Macrophages 
Mononuclear phagocytes are myeloid cells that include monocytes, macrophages and 
dendritic cells. Circulating monocytes differentiate into dendritic cells or macrophages once they 
leave the bloodstream. Unlike neutrophils, which are thought to be primarily involved in killing 
pathogens, macrophages have a diversity of roles, including pro- and anti-inflammatory 
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signaling, phagocytosis and killing of pathogens and dead or dying cells, and antigen 
presentation (153). Macrophages come in several varieties: resident macrophages regulate 
repair and regeneration in tissues, activated inflammatory macrophages attack pathogens and 
present antigens in order to activate adaptive immunity. Different organs have their own 
specialized populations of macrophages such as microglial cells in the central nervous system 
or alveolar macrophages in the lungs.   
Macrophages play a prominent role in protection from disseminated Candidiasis (154–
156). In mucosal candidiasis, evidence thus far indicates that their activities are non-essential 
(142, 157). However, their presence at mucosal sites and their known roles in signaling and 
antigen presentation indicate that their activities may play a role in mucosal candidiasis.  
The first step in phagocytosis by mononuclear cells is the recognition of Candida via 
Dectin-1 in cooperation with other PRRs (154, 158). Macrophages are less effective than 
neutrophils in killing fungi; yeast are able to survive and replicate in macrophage phagosomes 
(37). In vitro, phagocytosed yeast can switch to hyphal growth, activate cell death pathways and 
kill macrophages by lysing them (86). However, in vivo imaging in the zebrafish showed that 
macrophages allow replication but prevent germination of yeast (64). In some cases, 
macrophages provide a protective niche where fungal pathogens can evade killing by 
neutrophils and thus promote pathogenesis (159–161).  
Resident macrophages are the first to encounter invading Candida and sound the alarm. 
In addition to phagocytosing and killing pathogens, they play a protective role in disseminated 
Candidiasis by signaling with cytokines and chemokines (CXCL1, IL-6 and TNFa) to recruit and 
activate more phagocytes (154, 155, 162). In mucosal Candida infection, this signaling role is 
likely shared with epithelial cells and other cell types. In the gut, signaling by resident 
macrophages dampens responsiveness to commensals. When macrophage signaling is 
disrupted, neutrophil-mediated inflammation results (163, 164).  
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PBMCs respond differently to C. albicans and C. parapsilosis and differences in their cell 
wall components are likely to be involved (165). In in vitro comparisons, peripheral blood 
mononuclear cells (PBMCs) produced cytokines in response to heat-killed C. albicans or C. 
parapsilosis but with different levels of key cytokines involved in T-helper cell differentiation 
(166, 167). Macrophages exhibit a preference for phagocytosing C. albicans yeast over hyphae 
in vitro (168). 
1.5.2.6 Cooperation and cross-talk in mucosal tissue 
Mucosal epithelial tissues are made up of many cell types. In this complex environment 
all the cell types need to communicate appropriately with each other in order to protect us from 
pathogens and also to avoid damage from excess inflammation. This is one of the strongest 
arguments for studying host cell interactions during mucosal candidiasis in a live host. Some 
examples of cell-cell interactions follow.  
In vitro responses often differ depending on the presence or absence of other cell types. 
When neutrophils (PMNs) were added to reconstituted oral epithelial models they enhanced 
expression of cytokines, cathelicidin and  b-defensins by epithelial cells and protected the 
epithelium from invasion and damage (169, 170). 
It is well-established that immunity to oropharyngeal candidiasis depends on IL-17 
signaling. The Leibundgut-Landmann and Gaffen labs have elucidated the cell-type specific 
communication related to IL-17’s protection against Candida. Using a mouse model of 
oropharyngeal candidiasis, they found that dendritic cells produced cytokines (IL-1b, IL-6, and 
IL-23) to induce IL-17 production and that the majority of IL-17 production could be attributed to 
innate lymphoid cells (and not Th17cells) (171, 172). IL-17 is detected by oral epithelial cells 
which then release b-defensin-3 to control Candida infection (111). IL-1 receptor is essential for 
both the recruitment and hematopoiesis of neutrophils that protect the host from OPC. The IL-
1a cytokine signal is produced by keratinocytes in the Candida-infected tongue and received by 
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endothelial cells, which are the primary source of GM-CSF, a cytokine responsible for inducing 
the generation of new neutrophils from the bone marrow (173).  
Finally, the effector functions of phagocytes are affected by the presence of their 
partners. Neutrophil and macrophage phagocytosis and killing in Candida challenges of a single 
phagocyte type were altered when the two phagocyte types were cocultured together with C. 
albicans (174).  
In conclusion, Candida colonization and infection of the mucosal epithelium is a complex 
situation involving interactions among many host cell types and the pathogen. While in vitro 
experiments testing the interactions of single cell types with fungal pathogens can yield 
important information, it’s essential that the results be verified in a live infection model where a 
natural complement of cell types are present. 
1.6 Models of Candida Infection  
To learn about host-pathogen interactions during infection, one must have a good 
model. Researchers must consider how closely the model reflects human disease, the number 
of replicates needed, the ease of use, and the ability to manipulate the genetics of the model 
(175). In this section, I will review the characteristics, advantages and disadvantages of in vitro 
and in vivo models that have traditionally been used to study candidiasis. I will devote section 
1.7 to describing the model used in this dissertation, the zebrafish.  
1.6.1 In vitro models 
Much of what is known about the interactions between host cells and Candida has been 
discovered using in vitro models. These include leukocytes from human blood donors, bone 
marrow-derived macrophages/monocytes, mouse cell lines and human epithelial cell cultures. In 
vitro models allow the experimenter exquisite control over the physiochemical environment and 
ensure homogeneity of cell types. They enable the testing of pathogen or host cell mutations, 
treatments and drugs in an environment that isolates the effects of these factors. Many in vitro 
experiments utilize live cell imaging to track host-pathogen interactions. Their simplicity is an 
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advantage but also comes with a caution – what is seen in vitro doesn’t always translate to the 
live host.  
1.6.1.1 Epithelial cell models   
The simplest epithelial models are monolayers of epithelial cells. These can be primary 
cell cultures started from mouse or human tissue or, alternatively, immortalized epithelial cell 
lines can be used. For a more realistic model, 3-dimensional organotype epithelial models of 
human oral and vaginal mucosa have been created by growing epithelial cells on an inert 
polycarbonate filter in defined media (176). Three-dimensional models of oral mucosae can be 
made more realistic by growing them in a flow chamber with a saliva-like media and on a 
collagen gel embedded with fibroblasts (177, 178). Researchers have argued for the value of in 
vitro models made from human as opposed to murine epithelial cells for studying C. albicans 
because this fungus is primarily a human pathogen and doesn’t naturally infect mice. 
1.6.1.2 Models of phagocyte-Candida interactions. 
Parameters of the fungus and the host that affect host cells’ ability to phagocytose 
Candida have been explored in suspension cultures of host cells. Protocols involve fluorescent 
labeling of yeast prior to coincubation with phagocytes, quenching of that labeling or secondary 
labeling of extracellular yeast, and fluorescent antibody labeling of host cells, followed by 
fluorescence microscopy or flow cytometry to detect the number of host cells with internalized 
yeast and the number of yeasts per phagocyte (179, 180). Suspension co-cultures mimic 
phagocyte/pathogen encounters in the blood stream, but in the live host, phagocytes more often 
encounter pathogens within tissues.  
Models that include aspects of the tissue environment can more closely resemble the 
surroundings of phagocytes in vivo. As they move through tissues, phagocytes encounter 
extracellular matrix components. In vitro experiments showed that incorporating these 
molecules altered phagocyte responses to pathogens (181, 182). In another example, 
neutrophils tested in a model that mimics the endothelial lumen had increased longevity and 
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faster migration towards pathogens (183). These more realistic in vitro models will help to make 
sense of differences between the results of previous in vitro work and in vivo experiments and 
human clinical data.  
1.6.2 In vivo models 
Animal models bridge the gap between cell culture findings and human trials and are an 
absolutely essential part of the research process. The challenge is to choose a model that is 
representative of the human infection environment while balancing the needs of the researcher. 
For the study of mucosal candidiasis, rodent models have been the standard. However, small 
vertebrate animals (zebrafish, Danio rerio) and invertebrates (e.g. Drosophila melanogaster, 
Galleria mellonella, Caenorhabditis elegans) have been used successfully and have gained 
respect for their ease of handling, genetic manipulation, and microscopy, plus their relatively low 
cost.  
1.6.2.1 Mouse and rat models 
Rodent models have been used to study mucosal candidiasis at the body sites where it 
is found in humans: oropharynx, gut, and vagina. A model to study oral candidiasis was 
developed in rats using an acrylic device to mimic dentures. Oral infection in mice is only 
established after immunosuppression, treatment with antibiotics, or in mice with genetic defects 
in immunity (184, 185). C. albicans is not a natural commensal of rodents, which can be seen as 
an advantage in that the subjects will not have developed adaptive immunity to the organism 
prior to inoculation, allowing the study of the initial innate response.  
Rats were the first rodents used to model Candida vaginitis, but mice have been used in 
recent experiments. In both rats and mice, the animals must be treated with estrogen to 
establish infection. This parallels human infection, where hormone levels affect susceptibility 
(184, 186). The mouse model recapitulates human infection in characteristics of the immune 
response including the production of neutrophil chemoattractants, neutrophil infiltration, and the 
fact that protection is associated with the absence of a pro-inflammatory response (186).  
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As mammals, rodents have many characteristics of human subjects. For example, their 
body temperature approximates that of humans, which is important to the study of C. albicans 
since morphotype switching and growth is affected by temperature. Despite their many 
advantages, rodent models present some difficulties. Rodents are expensive to house and care 
for. Creating knock-outs is time-consuming and labor intensive. Ethical considerations require 
the use of only a few experimental subjects, making it difficult to detect small differences 
between experimental treatments. In vivo imaging of fungal infection in rodents is limited in both 
time and in which tissues are accessible. 
1.6.2.2 Invertebrate models 
The fruit fly, Drosophila melanogaster, the nematode, Caenorhabditis elegans, and the 
larva of the insect Galleria mellonella have been developed as models for fungal infection (187–
189). Their advantages are lower expense and the ability to use large numbers of animals per 
experiment. C. elegans and D. melanogaster can be inoculated by ingestion of fungi in their diet 
saving time over animals that need to be inoculated individually by injection. These 
invertebrates lack an adaptive immune system but possess hemocytes that function similarly to 
mammalian phagocytes. They are ideal for high throughput studies comparing different Candida 
species or mutants. An advantage of Galleria is that they can be kept at 37 C, the appropriate 
temperature for a human commensal like Candida. C. elegans has a transparent cuticle so 
intravital imaging of the whole animal is possible. 
1.7 Zebrafish Models of Fungal Infection. 
The zebrafish is essentially the only tiny vertebrate model in use for the study of Candida 
infection and is the model used in this dissertation. Therefore, I will devote a section of this 
literature review to a description of its advantages and the findings that it has facilitated. Much of 
the material in this section was written by the author and her advisor for publication in a review 
article entitled “The Zebrafish as a Model Host for Invasive Fungal Infections” (190). 
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The larval zebrafish has many of the advantages of invertebrate models: ease of care, 
access to large numbers of experimental animals, and relatively low cost. Over the past ten 
years, work from several laboratories has established mucosal, disseminated and localized 
infection models in zebrafish larvae, taking advantage of the transparency of the zebrafish larva 
to monitor single-cell dynamics over the long-term to understand determinants of infection 
progression, pathogenesis and immune response (160, 191–194). These studies have revealed 
numerous parallels between zebrafish and mammalian infection models, extended in vitro 
studies into a vertebrate host, and uncovered new and unexpected aspects of host-pathogen 
interaction in vivo.  
1.7.1 The zebrafish toolkit  
Because of the ease of live imaging, larval zebrafish provide an ideal model in which to 
investigate phagocyte–fungal pathogen interactions and host cell signaling. The small size of 
the zebrafish larva makes diffusion sufficient for gas exchange thus providing opportunities to 
view host cell–pathogen interactions in vivo. Additionally, living larvae can be imaged for 
multiple days in a row to follow the entire progression of an infection, another unique advantage 
of the system. To visualize the host side of these interactions, multiple established zebrafish 
lines exist which label neutrophils and macrophages or mark inflammatory gene expression 
(195–199). In addition, many models of immune deficiency are established in the zebrafish 
(200–203). 
1.7.2 Phagocyte interactions with fungal pathogens 
Established genetic and experimental methods for depletion of macrophages or 
inactivation of neutrophils allow for the specific contributions of these cell types to be elucidated 
(142, 191, 201, 204–206). In the zebrafish, neutrophils and macrophages are recruited to yolk, 
hind-brain, and swimbladder infections of C. albicans. Using tools to manipulate signaling and 
phagocyte recruitment, a picture is emerging of the roles and activities of these innate immune 
cell populations, with interesting new findings. One conundrum in the field has been that 
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macrophages are important in immunity to C. albicans in vivo, but when isolated macrophages 
ingest yeast, the fungi germinate and kill the macrophages rapidly and efficiently in vitro (13, 
207–209). However, during C. albicans infection in the zebrafish it is clear that macrophages 
can prevent fungal germination and thereby provide a crucial brake on the infection. In fact, the 
efficiency of fungal ingestion within the first four hours of infection is crucial for overall survival 
(210). The engulfed yeast were found to survive, divide, then exit macrophages far from the 
infection site (Brothers et al., 2013; Scherer et al., manuscript in preparation), suggesting that C. 
albicans has a mixed intra-/extra-cellular lifestyle during infection that includes Trojan horse-
mediated fungal dissemination.  
Early phagocyte containment could be enhanced by opsonizing antibodies and is a 
crucial determinant of overall survival in the hindbrain ventricle infection model (210, 211). 
Experiments also found that macrophage recruitment to filamentation-competent C. albicans 
requires both phagocyte oxidase (Phox) and dual-specific oxidase (Duox), revealing a new role 
for NADPH oxidases in phagocyte recruitment (210). In addition to phagocyte recruitment, 
zebrafish also allow for the assessment of phagocyte activation and recent work in both the 
swimbladder and yolk models of infection demonstrate that the major cell type expressing TNF-
α at the site of infection is the macrophage, whose presence there drives large increases in 
TNF-α expression host-wide (Archambault et al., 2019, Scherer et al., manuscript in 
preparation). Taken together, these studies in the larval zebrafish have expanded our 
appreciation for the versatility of C. albicans, identified a new role for NADPH oxidases in the 
immune response and highlighted the importance of rapid macrophage responses in limiting 
lethal infection. 
Neutrophils engulf C. albicans yeast and attack filaments in both the hindbrain ventricle 
and swimbladder (142, 210). Neutrophilic attack drives production of extracellular traps in the 
swimbladder and limits hyphal penetration of the epithelial barrier, providing a crucial element to 
mucosal immunity (142). This neutrophil response requires both PI3K and CXCR2, as in 
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mammalian systems (142). Extracellular neutrophil histones suggestive of neutrophil 
extracellular traps (NETs) were also observed after hindbrain infection with C. albicans (41). 
Several reporter strains of C. albicans have also been used in larval zebrafish to probe 
the micro-environmental conditions of the fungi during infection. This has included sensors for 
oxidative stress (210), arginine starvation (213), and hyphal growth (211), revealing 
microclimates within the host to which the fungi are exposed. The ability to visualize infection 
has deepened our appreciation for mechanisms discovered in simplified cell culture interactions 
and has also sparked new hypotheses about fungal virulence and immunity that remain to be 
tested in mammalian systems. 
1.7.3 Sites of infection  
As vertebrates, zebrafish have multiple organs and anatomical sites for infection that are 
analogous to those in mammalian models and human hosts. An advantage in zebrafish is the 
ability to view the entire organism to follow the progression of infection (i.e. dissemination). The 
fish lacks some organs important in human fungal infections (lungs, for example) so it’s 
important to choose the best model to suit the experimental question.  
1.7.3.1 Yolk 
Injection of Candida into the embryonic zebrafish yolk sac is straightforward and can 
lead to systemic infection. The yolk sac provides nutrients to the developing larva and is 
surrounded by the yolk syncytial layer (YSL) which separates the yolk from the fish body proper 
(214, 215). Early work using the embryonic zebrafish yolk showed that phagocytes were 
recruited to this site in response to sterile injury and to C. albicans infection (216, 217). These 
phagocytes likely arrive through a network of blood vessels in close proximity to the yolk which 
may also give pathogens potential routes of dissemination (218). 
The yolk can be an excellent location for detailed imaging of phagocyte-fungal 
interactions. In a recent study, this injection site was used in zebrafish with macrophages 
expressing a photo-switchable reporter to show macrophages suffered a different fate after 
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interacting with C. albicans. Once they had interacted with the pathogen, macrophages tended 
to remain in the infection area and were more likely to die than “bystander” macrophages (219). 
Currently, the yolk infection site is being used to dissect the complex web of host and pathogen 
factors contributing to the dissemination of C. albicans and has already led to the surprising 
discovery that yeast and hyphae do not synergize with each other in promoting dissemination 
(Seman et al., 2018; Scherer et al., manuscript in preparation).  
1.7.3.2 Hindbrain ventricle  
The hindbrain ventricle (HBV) is a clear, fluid-filled space that can be inoculated via 
microinjection at 36-48 hpf (190). It is normally free from phagocytes so is especially well-suited 
to visualizing phagocyte recruitment and interactions through the thin epithelial layer covering 
the HBV. Although the HBV has no structural homology to mammalian structures, the ease of 
injection and subsequent imaging make it a worthwhile model for phagocyte-pathogen 
interactions. 
Injection of C. albicans into the HBV led to insights into Chronic Granulomatous Disease 
(CGD), a defect in host production of reactive oxygen species (ROS), which predisposes 
patients to disseminated fungal infection (220, 221). While ROS were previously known to play 
a role in the killing of C. albicans in vitro, live imaging of infected zebrafish embryos enabled the 
discovery of a separate role in promoting chemotaxis. Treating zebrafish with DPI or 
morpholinos to mimic CGD showed that both phagocyte oxidase (Phox) and dual-specific 
oxidase (Duox) play signaling roles in phagocyte recruitment, which promotes containment of 
infection and survival of the host, not by the immediate killing of C. albicans but by recruiting 
phagocytes which then ingest it and limit its germination (210). 
Because containment of C. albicans by phagocytes at this site is closely tied to host 
survival, the HBV model is ideal to test the utility of biological antifungal therapies (211). It was 
found that non-specific human IgG enhances phagocytosis by zebrafish phagocytes and that 
polyclonal anti-Candida antibodies enhance containment of fungi in vivo and promote survival. 
  34 
Thus, this model is useful for testing antifungal therapies that could enhance innate immune 
activity against C. albicans.  
C. albicans cells that are not heterozygous at the mating-type loci are competent to 
switch between white and opaque forms (222). White cells are in general more virulent, 
although opaque cells have some enhancement in virulence at lower temperatures, something 
that has only been testable in the larval zebrafish because of its flexibility in body temperature 
(223). Interestingly, opaque cells are poorly phagocytosed by mammalian and zebrafish 
phagocytes both in vitro and in vivo, which would potentially allow them to avoid phagocytic 
containment and permit them to grow as potentially pathogenic filaments (223). 
1.7.3.3 Swimbladder 
The zebrafish swimbladder is a mucosal, epithelial-lined, air-filled organ that functions to 
maintain and adjust buoyancy. The swimbladder displays homology with the mammalian lung in 
terms of anatomy, development, and gene expression (224–227), providing a clinically relevant 
model for fungal infections of the lungs such as Aspergillus and Cryptococcus. The swimbladder 
forms as an outgrowth of the foregut at 36-48 hours post-fertilization (hpf) and by 60 hpf, the 
swimbladder consists of three layers: an inner epithelium, a middle mesenchymal layer in which 
nerves and blood vessels are embedded, and an outer mesothelial layer (224, 227). While the 
larval zebrafish swimbladder lacks the complexity of mature mammalian mucosal epithelial 
surfaces, such as the tongue or intestine, ease of injection and imaging make it a suitable 
general model and a good bridge between cell culture and mammalian models. Its versatility is 
illustrated by its successful use in the study of a variety of infections including those caused by 
Mucor circinelloides, Influenza A virus and Candida albicans/Pseudomonas aeruginosa 
coinfection (191, 228, 229) 
The zebrafish inflates the swimbladder with air at around 4.5 days post-fertilization (dpf), 
and injection of microorganisms into the swimbladder lumen is a relatively simple endeavor. 
Interactions between pathogens and host cells can be easily monitored at this site, as it is 
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patrolled by phagocytes of the innate immune system which are recruited in greater numbers in 
response to infection, LPS and sterile injury (230, 231). As in mucosal infection in vitro and in 
mammalian models, zebrafish activate NF-kB in the swimbladder tissue and express 
inflammatory cytokines in response to C. albicans infection (230). The air bubble creates a clear 
optical background which enhances imaging at the inner surface of the swimbladder. However, 
the air bubble also makes the swimbladder the thickest part of the larva, so imaging is usually 
limited to one half the width of the swimbladder, and the relatively later age at which the swim 
bladder develops limits experiments to later larval stages. The entire organ can be dissected for 
clearer imaging of interactions between host epithelial cells, phagocytes, and fungal yeast or 
hyphae (212, 230, 232).  
One example of an advance made possible by the swim bladder model, and the ability to 
longitudinally track infection progression and outcome in individual zebrafish larvae, is a study of 
tri-kingdom interactions between C. albicans, P. aeruginosa and the zebrafish host (229). These 
pathogens are often co-isolated in human lung infections, particularly in cystic fibrosis patients. 
Bergeron et al. found a synergistic interaction between the two pathogens that led to elevated 
inflammation, as indicated by higher IL-6 expression and swimbladder edema, and increased C. 
albicans pathogenesis that manifested in greater fungal burden and more frequent epithelial 
invasion by fungal hyphae.  
1.7.3.4 Egg 
Infection of the zebrafish egg has been investigated as an approach for testing pathogen 
characteristics (233–237). While infection at this embryonic stage occurs before the 
development of many immune system components (238), the potential of this model lies in its 
applicability to high-throughput screens and studies. Two groups have developed robotic 
methods for injecting into the yolk of very early zebrafish embryos still within the chorion; one 
utilized computer image recognition to guide the needle (236) while the other used an agarose 
grid of dimples to hold the eggs, which naturally aligned themselves with the cellular material to 
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the side, making yolk injection without visual guidance possible (234). Using a bath infection 
method at 1 dpf, a recent study found a novel gene, ORF 19.1725, to be involved in C. albicans 
adhesion, penetration, and virulence (239). 
1.7.3.5 Peritoneal cavity  
While I have been focused on the utility of larval zebrafish, adult zebrafish also have 
advantages as a model. For example, the adaptive immune response to fungal infection can be 
studied in adult zebrafish (240, 241). In fact, the earliest use of zebrafish for the study of C. 
albicans infection employed intraperitoneal injection of adult fish, which showed that many 
aspects of Candida infection in mice could be replicated in the zebrafish model (217). These 
infections have yielded valuable transcriptome data from both host and the pathogen during 
infection (242). Combined with existing protein–protein interaction networks, these data have 
generated hypotheses about host and pathogen interactions at different stages of infection 
(243–245).  
1.7.4 Conclusion 
The zebrafish is a valuable model for the study of host-pathogen interactions. Molecular 
and genetics tools have been developed and it is an affordable alternative to mammalian in vivo 
models. The limitations of the zebrafish (lack of adaptive immunity, temperature restrictions) 
require that the researcher carefully consider the questions best probed with this model. The 
ability to visualize infection has deepened our appreciation for mechanisms discovered in 
simplified cell culture interactions and has also sparked new hypotheses about fungal virulence 
and immunity that remain to be tested in mammalian systems.  
1.8 Chapter Summary 
In this introductory chapter, I hope I have provided an understanding of the complexity of 
host-microbe interactions at our mucosal surfaces. For my dissertation project, I chose the 
zebrafish swimbladder infection model to probe host immunity in mucosal infections by two 
species of the fungus, Candida. Intra-vital imaging of transgenic zebrafish with fluorescently 
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marked macrophages and neutrophils allows a close-up view of the interactions between 
phagocytes and fungal cells. Fish with fluorescent reporters for inflammatory signaling can help 
to elucidate the intricate dance of signaling and response that must occur in mucosal tissues to 
balance tolerance of commensals with protection from pathogens.  
In modern medicine, physicians are frequently forced to balance immune suppression 
against immune stimulation to treat patients such as those undergoing transplants and 
chemotherapy. It is my intention that this work will provide a clearer picture of the roles of 
professional and non-professional innate immune cells that our new understanding will lead to 
better-targeted therapies designed to preserve immunity and prevent opportunistic fungal 
infection in vulnerable patients. 
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CHAPTER 2 
INTRAVITAL IMAGING REVEALS DIVERGENT CYTOKINE AND CELLULAR IMMUNE 
RESPONSES TO CANDIDA ALBICANS AND CANDIDA PARAPSILOSIS 
 
2.1 Introduction 
Fungal species of the genus Candida are commensals on mucosal surfaces in healthy 
human hosts but cause both invasive and mucosal Candidiasis when immune defenses are 
compromised(32, 246). While Candida albicans is the species most commonly isolated from 
patients, infections due to C. parapsilosis are increasing, especially in neonates born 
prematurely (42, 43, 247). In healthy hosts, Candida is maintained as a commensal through the 
defenses of professional immune cells and the barrier functions of the mucosal epithelium. 
When these defenses are compromised, mucosal candidiasis ensues (32, 248). Understanding 
how host cells at mucosal surfaces interact with the fungal cells and how they coordinate their 
anti-fungal defenses will inform our attempts to prevent both systemic and mucosal disease (18, 
249).  
The mucosal epithelium is a complex environment and protection from mucosal 
candidiasis requires the combined actions of several cell types. In addition to their barrier 
functions, epithelial cells respond to Candida by inhibiting Candida growth with antimicrobial 
peptides and recruiting immune effector cells with alarmins and pro-inflammatory cytokines 
(173, 250–252). Among immune cells, neutrophils play key roles in defense at mucosal surfaces 
and in preventing dissemination of C. albicans (38, 253). In vitro, neutrophil/epithelial cross-talk 
provides protection from C. albicans (254–256). However, neutrophil activity must be tightly 
controlled as evidenced by its role in worsening symptoms of vulvovaginal candidiasis (27, 257, 
258). Monocytes/macrophages are essential for establishing protective immunity to 
disseminated infection but their role in mucosal infection is not completely clear (154–156, 259, 
260). Evidence from mouse and zebrafish models points to the redundancy of macrophages in 
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mucosal C. albicans infections (142, 157). However, macrophages have been shown to protect 
against other fungi in mucosal infection (261–264). C. parapsilosis is known to interact with 
macrophages and monocytes in vitro but the roles of phagocytes in controlling C. parapsilosis 
infection have not yet been explored in any live vertebrate infection model.  
Epithelial cells and patrolling phagocytes are the first host cells to detect pathogens and 
signal to coordinate defenses against mucosal candidiasis (24, 112, 248). In vitro experiments 
with single cell types have shown that epithelial cells and phagocytes differ with respect to 
inflammatory signaling during challenge by C. albicans and C. parapsilosis. Epithelial cells from 
oral and intestinal sources (oral cell lines SCC15 and TR146 and primary human enterocyte cell 
line H4) respond in vitro to C. albicans by producing pro-inflammatory cytokines but produce 
little cytokine response to C. parapsilosis (135, 254, 265). On the other hand, professional 
innate immune cells, including human peripheral blood mononuclear cells, murine peritoneal 
macrophages, and the murine macrophage cell line J774.2, produce pro-inflammatory cytokines 
in response to both heat-killed C. albicans and C. parapsilosis (165–167). These contradictory 
results make it difficult to predict how the different cell types in mucosal tissues coordinate 
defense against these opportunistic fungal pathogens, so we sought to measure immune 
responses in a tractable vertebrate mucosal infection model.  
In vitro experiments are limited to a few host-cell types and in vivo imaging in 
mammalian models is technically difficult (169, 266, 267). Complex signaling interactions 
between different host cell populations during mucosal Candida albicans infection were hinted 
at in studies using in vitro models with two or more host cell types (255, 256) and have been 
further elucidated using fluorescence-activated cell sorting of infected mouse tissue (171–173). 
Although these studies have shed light on the signaling roles and interactions of various host 
cell types with C. albicans, there remain significant gaps in our knowledge about the dynamics 
and cell-type specificity of immune responses in the host, especially with respect to infections 
with other clinically important Candida species such as C. parapsilosis. To further explore these 
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in vitro and in vivo findings using intravital imaging, we turned to the zebrafish swimbladder 
mucosal model, which mimics many aspects of mammalian infection (142, 230). The 
swimbladder is a natural site of fungal infection initiation in the fish that shares functional, 
anatomical, ontological and transcriptional similarities to the lung (224, 226, 227, 268–274). We 
compared the mucosal immune response to two clinically relevant Candida species in an 
environment containing multiple host cell types, measuring several aspects of the immune 
response, including pathway activation, cytokine production and innate immune recruitment. 
While C. albicans activated nuclear factor kappa B (NF-kB) signaling and elicited a strong pro-
inflammatory cytokine response at this mucosal site, the host inflammatory response to C. 
parapsilosis was muted, similar to what has been found in vitro for epithelial cells. Live single-
cell imaging suggests that NF-kB activation and tumor necrosis factor alpha (TNFα) 
upregulation occur in different cellular subsets. Interestingly, the inflammatory cytokine 
response was not predictive of phagocyte behavior, as neutrophils and macrophages were 
recruited to and attacked both Candida species. Nevertheless, neutrophils were essential for 
protection only from C. albicans but not C. parapsilosis, confirming their known role in attacking 
hyphae. The differential immune responses to the two species reveal a disconnection between 
chemokine production and phagocyte recruitment. Single-cell intravital imaging further suggests 
that there is tissue-specific activation of NF-kB and TNFα expression in mucosal candidiasis. 
2.2. Results 
2.2.1 C. albicans causes lethal infection but C. parapsilosis does not.  
C. parapsilosis and C. albicans are opportunistic pathogens that live commensally on mucosal 
surfaces of healthy humans and elicit different reactions from immune and epithelial cells in vitro 
(135, 265). To explore the relative virulence of these two fungal species in the mucosal setting 
in a live vertebrate host, we modified the zebrafish swimbladder infection model previously 
developed in our lab (142, 230, 275). We infected with a larger inoculum of 50-100 yeast to 
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promote morbidity without immuno-compromising the host (Fig. 2.1A). Both Candida species 
grew readily in the swimbladder, with C. albicans covering about twice as much area as C. 
parapsilosis by 24 hours post infection (hpi) (Fig. 2.1B). In the high-inoculum infection of 
immunocompetent fish used in this study, the swimbladder remained fully inflated and appeared 
healthy in the first hours after infection (Fig. 2.1C). However, within 24 hpi signs of disease were 
apparent, with swimbladders becoming partially (Fig. 2.1D) or completely (Fig. 2.1E) deflated. 
Over time, the swimbladder could become greatly distended (Fig. 2.1F) and in C. albicans 
infections, hyphae sometimes breached the swimbladder epithelium, a factor predictive of fish 
death (142, 229). C. parapsilosis infection caused no mortality within 4 days post-infection (dpi), 
while C. albicans-infected animals began to perish at 2 dpi and reached 20% mortality by 4 dpi 
(Fig. 2.1G). Thus, in these high-inoculum infections, only C. albicans caused patterns of disease 
leading to mortality that were similar to those previously seen in immunocompromised fish and 
in a mixed fungal/bacterial infection (142, 229). 
2.2.2 Zebrafish infected with C. albicans produce higher levels of inflammatory 
cytokines than C. parapsilosis-infected fish.  
Because we saw differences in the severity of the infections, we expected to find 
different inflammatory responses to the two Candida species. We measured changes in the 
expression of six inflammation-associated cytokines at 24 hpi (Fig. 2.2). In C. albicans infection, 
expression was significantly elevated above control levels for all six cytokines and higher than 
observed in C. parapsilosis infection for 4 of 6 cytokines. In contrast, in C. parapsilosis-infected 
fish, the median levels of cytokine expression were not significantly elevated above controls. 
Thus, C. albicans evokes a stronger whole-fish cytokine response than C. parapsilosis during in 
vivo mucosal infection, demonstrating that there are important differences in the immune 
response at this early time point—hours before mortality is observed.  
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Figure 2.1. C. albicans is more virulent than C. parapsilosis in the zebrafish swimbladder 
infection model. (A) Zebrafish were infected in the swimbladder at 4 days post-fertilization (dpf) 
with 50-100 yeast. (B) Candida burden at 24 hours post infection (hpi) as quantified from 
confocal z-projections. Data were pooled from 4 experiments. (C-F) Examples of infected 
swimbladders in Tg(mpx:mCherry):uwm7Tg zebrafish, infected with C. parapsilosis (C, D) or C. 
albicans (E, F). Depicted are: normal appearance of swimbladder (C; 6hpi), partial swimbladder 
deflation (D; 24 hpi), complete deflation (E; 24 hpi), distended swimbladder (F; 24 hpi). Scale 
bars: 150 µm. Dotted white line indicates boundary of swimbladder. (G) Injected fish were 
monitored for survival for 4 dpi. Data pooled from 3 independent experiments. Statistics as 
described in Materials and Methods. *, P<0.05, **, P<0.01.   
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Figure 2.2.  C. albicans elicits higher levels of cytokine expression than C. parapsilosis. 
Zebrafish were infected at 4 dpf as above. At 24 hpi, total RNA was extracted from groups of 9-
14 fish. Gene expression levels were determined by qPCR relative to mock-infected fish using 
the 2-∆∆Ct method. Data from 11 independent experiments. Notations above each bar indicate 
the significance of the difference between experimental treatments and vehicle-injected 
controls. Notations above the brackets indicate if there was a difference between C. parapsilosis 
and C. albicans-infected fish. Statistics as described in Materials & Methods: *, P<0.05, **, 
P<0.01, ***, P<0.001, ****, P<0.0001, (ns) not significant, P>0.05). Abbreviations: serum 
amyloid A (saa), tumor necrosis factor (tnf)-α, interleukin-10 (il-10), C-C motif chemokine ligand 
2 (ccl2), C-X-C motif ligand 8 (cxcl8), interleukin-6 (il-6). 
 
2.2.3 The local inflammatory signaling pattern mirrors whole-fish cytokine levels. 
The whole-fish qPCR data showed overall cytokine responses but did not give us any 
spatial information about inflammatory signaling or indicate the cell types involved. In the 
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zebrafish, local immune activation and cytokine signaling by epithelial tissue and innate immune 
cells can be imaged in real time in the live host. Two key signaling components activated by 
Candida are NF-kB and TNFα (134, 158, 230, 276–278). TNFα expression is activated 
downstream of NF-kB and other signaling pathways, and is implicated in protective cross-talk 
between polymorphonuclear cells and the oral epithelium (256, 279).  
To detect activation of NF-kB at the infection site, we used a transgenic zebrafish line 
Tg(NF-kB:EGFP) that reports on pathway activity in multiple cell types and is activated in the 
swimbladder upon mucosal infection (195, 230). Imaging of infected fish at 24 hpi revealed 
significant induction of NF-kB in C. albicans-infected fish but only basal levels of activity in C. 
parapsilosis-infected fish (Fig. 2.3A-D). As expected, we found GFP expression in several 
tissues, but not the swimbladder, under homeostatic conditions (195). To visualize local 
cytokine expression, we used TgBAC(tnfa:GFP)) reporter fish (196). Again, we only saw 
significant activation of tnfa:GFP in C. albicans and not C. parapsilosis infections (Fig. 2.4A-D). 
 
Figure 2.3. Transcription Factor NF-kB is activated during C. albicans but not C. 
parapsilosis infection. Transgenic Tg(NF-kB:EGFP) zebrafish were infected and imaged as 
above. (A-C) Images representing the median level of NF-kB activation for Vehicle (A),  
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Figure 2.3 continued. C. parapsilosis (B), and C. albicans (C) injections. Maximum projections 
of 12 z-slices. Left: overlay of fluorescence and DIC. Middle column: overlay of fluorescence 
with dotted outline of swimbladder. Right column: thresholded image for quantification. (D) 
Quantification of NF-kB activation. Data from 3 independent experiments. All scale bars: 150 
µm. Statistics as described in Materials & Methods: *, P<0.05, **, P<0.01, ***, P<0.001, n.s. not 
significant, P>0.05.  
 
 
Figure 2.4. Pro-inflammatory cytokine TNFα is expressed during C. albicans but not C. 
parapsilosis infection. (A-D) TgBAC(tnfa:GFP) reporter fish were infected and imaged at 24 
hpi as above. (A) Quantification of TNFα expression. Data from 3 independent experiments. (B-
D) Representative images of swimbladders with median level of TNFα expression are shown for 
Vehicle control (B) and C. parapsilosis (C), and C. albicans (D) infections. Left column: 
Maximum projections of 15-18 z-slices. Right column, dotted outline of swimbladder. All scale 
bars: 150 µm. Statistics as described in Materials & Methods: *, P<0.05, **, P<0.01, ***, 
P<0.001, n.s. not significant, P>0.05.  
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Intriguingly, despite the well-characterized connections between NF-kB and TNFα, our in 
vivo imaging revealed differences in the spatial patterns of NF-kB activation and expression of 
TNFα during C. albicans infection. NF-kB:EGFP fluorescence was more diffuse (Fig. 2.3C) 
while tnfa:GFP expression was more punctate and visible mainly near C. albicans yeast and 
hyphae (Fig. 2.4D). These patterns of activity were especially interesting because previous work 
has shown that, in addition to the resident phagocytes present without infection, there are 
recruited phagocytes present within the epithelial-lined swimbladder at this time post-infection 
(142, 229, 230)(see also below). 
2.2.4 Signaling patterns differ in macrophages and epithelial tissue.  
While live imaging of transgenic fish at low resolution narrowed the location of signaling 
to the infection site, it did not allow us to identify which cell types were activated and contributing 
to swimbladder fluorescence. Because of the differences in NF-kB and TNFα patterns, we 
reasoned that the two signaling components might be activated in different cell types. To 
examine cellular expression at high-resolution and distinguish between fluorescence within the 
swimbladder and fluorescence in overlying tissue, we dissected swimbladders from C. albicans-
infected zebrafish using the method previously developed in our laboratory (232). Imaging of 
Tg(NF-kB:EGFP) zebrafish swimbladders immediately after dissection revealed GFP-positive 
cells of the epithelial layer both near and distant from the area at the back of the swimbladder 
containing fungi (Fig. 2.5A). This is also illustrated in a single representative slice by outlining 
fluorescent cells and adding the tissue landmarks (Fig. 2.5B). In TgBAC(tnfa:GFP) zebrafish, 
GFP-positive cells were not seen in the epithelial layer but many GFP-positive cells were 
intermingled with yeast and hyphae (Fig. 2.5C). This is again illustrated in a representative z-
slice (Fig. 2.5D). The morphology and location of these cells is consistent with that of 
phagocytes.  
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Figure 2.5. Patterns of NF-kB activation and TNFα expression differ. Dissected 
swimbladders from C. albicans-infected fish were imaged at 24 hpi. (A) Z-projection of 3 slices 
of a dissected Tg(NF-kB:EGFP) swimbladder with moderate EGFP expression. (B) Single z-
slice from blue square in the z-stack in A, with outlines of fungi, EGFP+ cells and epithelial 
layers based on DIC image. (C) Z-projection of 7 slices of a TgBAC(tnfa:GFP) swimbladder with 
high GFP expression. (D) Single z-slice from blue square in the z-stack in A, with outlines of 
fungi, GFP+ cells and epithelial layers based on DIC image. Scale bars 150 µm (A, C), 50 µm 
(B,D). 
 
To further characterize these cells displaying immune activation we assessed their 
motility by crossing Tg(NF-kB:EGFP) or TgBAC(tnfa:GFP) fish with mpeg1:dTomato (red 
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macrophage; (199)) reporter fish and using time-lapse imaging to view the shape, behavior and 
identity of GFP-fluorescing cells in infected fish. We found in time-lapse experiments that 
mpeg1:dTomato+ macrophages were occasionally double-positive for NF-kB:EGFP or tnfa:GFP 
(Fig. 2.6A-B; 6/43 macrophages for NF-kB:EGFP and 7/35 macrophages for tnfa:GFP). Cells 
that are GFP+ are outlined and were followed for more than 16 minutes (Fig. 2.6Ai-iii and 2.6Bi-
iii). In TgBAC(tnfa:GFP) fish all GFP+ cells (7/7) were also dTomato+, indicating that they are 
macrophages, while this was only the case for a minority of GFP+ cells in Tg(NF-kB:EGFP) fish 
(5/57; Fig. 2.6Aii and 2.6Bii). Many GFP+ cells were motile in tnfa:GFP transgenics (5/7) but 
only a few were motile in NF-kB:EGFP transgenics (3/57; Fig. 2.6Aiii and 2.6Biii). This indicates 
that while TNFα expression in the swimbladder is limited to macrophages, NF-kB signaling is 
activated in both macrophages and other cells likely to be epithelial. Time lapse videos may be 
found attached to the published article reporting this work (212). 
Large, non-motile cells, in Tg(NF-kB:EGFP) fish such as cell #2 (Fig. 2.6Aiii, yellow 
dotted outline) were EGFP+ but dTomato-, suggesting they are not macrophages. In fact, the 
position and behavior of such cells suggest that they reside in the swimbladder epithelial layer, 
consistent with what is observed in dissected swimbladders (Fig. 2.5A, B). In TgBAC(tnfa:GFP) 
fish, some stationary cells, such as cell #4 in the time-lapse (Fig. 2.6Biii, yellow dotted outline), 
were interacting with Candida and were identified as macrophages based on their 
mpeg1:dTomato expression. These time-lapse data thus indicate that TNFα-expressing cells 
are more likely to be motile macrophages while NF-kB is most frequently activated in non-motile 
cells with epithelial morphology. 
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Figure 2.6. Tissue Partitioning of NF-kB activation and TNFα expression. Dissected 
swimbladders from C. albicans-infected fish were imaged at 24 hpi. (A, B) Still images from time 
lapses taken at 24 hpi. (A) Tg(NF-kB:EGFP) x mpeg1:dTomato (red macrophage) zebrafish at 
time = 0:00 of the time lapse in movie S1 (212). The leftmost image is a maximum-projection 
overlay of all colors using a middle plane from DIC. (Ai; column 2) Zoomed-in images of the 
areas outlined in the blue square. Dotted lines outline example cells that either moved (white 
outlines; cells 1, 3) or remained stationary (yellow outlines; cell 2) over the 16 minute-long time-
lapse. (Aii; column 3) The GFP channel was eliminated to demonstrate red fluorescence of 
macrophages. Cells 1 and 3 are dTomato+ (macrophages), while cell 2 is not. Aiii; column 4) 
Schematics showing the positions of each cell at the times indicated in the grayscale legend. 
Only cells 1 & 3 change shape or position. (B) TgBAC(tnfa:GFP) x mpeg1:dTomato zebrafish at 
time = 0:00 of the time lapse in movie S2 (212). (Bi; Column 2) Outlines of example cells (white; 
moved; cells 5 & 6; yellow; stationary; cell 4). (Bii; Column 3) Cells 4, 5, and 6 are dTomato+ 
(macrophages). (Biii; Column 4): Schematics showing movement over time. Cells 5 & 6 change 
shape and position over the course of the time lapse but cell 4 does not. Color channels: z 
projection of 13 (A) or 11(B) slices, DIC: single z-slice. Scale bars 150 µm (A, B), 50 µm (Ai-iii, 
Bi-iii). 
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2.2.5 Neutrophils are recruited to infection and attack both C. albicans and C. 
parapsilosis.  
The activation of NF-kB and expression of TNFα at the infection site in C. albicans-
infected fish, combined with the qPCR data showing that the chemokines CXCL8 and CCL2 
were only upregulated in C. albicans infection, suggested that phagocytes might be recruited 
only to C. albicans infections. We measured neutrophil recruitment using the 
Tg(mpx:mCherry)uwm7Tg fish line, which has been characterized to express red fluorescence 
almost exclusively in neutrophils (198). To our surprise, we found increased neutrophil 
recruitment compared to mock-infections (11/fish) for both C. parapsilosis (25/fish) and C. 
albicans (50/fish) infections (Fig. 2.7A-D).  
Because of the different cytokine milieu elicited by the two fungal species, we reasoned 
that there might be differential interactions of neutrophils with each species of fungi at the 
infection site. We examined z-stack images slice-by-slice and catalogued interactions between 
neutrophils and Candida (Fig. 2.7E-G). In C. albicans infection, significantly more neutrophils 
per fish were involved in interactions with the fungus, although this is not surprising considering 
their greater numbers in C. albicans-infected swimbladders (Fig. 2.7H). Interactions in which 
neutrophils had ingested C. parapsilosis (Fig 2.7E blue arrows) or C. albicans yeast cells (G, 
blue arrows) or were wrapped around C. albicans hyphae (“frustrated phagocytosis”) (Fig. 2.7F, 
yellow arrows) were counted as phagocytosis. When all neutrophils interacting with Candida 
were considered together, similar percentages were engaged in phagocytosis in C. parapsilosis 
(~65%) and C. albicans (~72%) infections (Fig. 2.7I). Thus, despite the lower numbers of 
neutrophils in C. parapsilosis infection and the differing cytokine environment, neutrophils had 
similar levels of activity against each fungal species.  
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Figure 2.7. Neutrophils respond to infections of both Candida species. 
Tg(mpx:mCherry):uwm7Tg zebrafish (red neutrophils) were infected as above and imaged at 24 
hpi. Data are pooled from 5 independent experiments. (A-C) Representative images from 
Vehicle (A), C. parapsilosis (B) or C. albicans (C) cohorts. Maximum projections, z-slices: n=19 
(A), n=18 (B), n=16 (C), with (left) and without (right) single DIC z-slice. (D) Neutrophils per fish 
in the swimbladder lumen at 24 hpi. (E-G) Examples of neutrophils (red) interacting with C. 
parapsilosis (E, green) or C. albicans (F&G, green). Interactions include contact, phagocytosis 
(E, G, blue arrows) and “frustrated phagocytosis” (F, yellow arrows). Maximum projections, n 
slices: n=3 (E, F), n=9 (G). (H) Neutrophils per fish involved in interactions with C. parapsilosis 
or C. albicans at 24 hpi. (I) Percentage of interacting neutrophils engaged in phagocytosis at 24 
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Figure 2.7 continued. hpi. (J) Neutrophils per fish interacting with yeast of C. parapsilosis, and 
yeast or hyphae of C. albicans. Number of neutrophils scored for Vehicle, C. parapsilosis and C. 
albicans, respectively: 191, 525 and 652. Statistics as described in Materials & Methods: *, 
P<0.05, **, P<0.01, ***, P<0.001, ****, P<0.0001, n.s., not significant, P>0.05. Scale bars: 150 
µm (A-C), 40 µm (E-G). 
 
Dimorphic switching of C. albicans is considered an important virulence trait, although 
little is known about how different morphotypes interact with immune cells in vivo. In the 
swimbladder, C. albicans injected as yeast switch rapidly to hyphal growth within the first 3 hpi 
(229, 232), and here we found that C. parapsilosis remains in yeast form throughout the 
infection period. Neutrophils were found interacting more often with C. albicans hyphae than 
with yeast, which could be due to the large number of hyphal segments present (Fig. 2.7J). 
Overall, these data are consistent with the known activities of neutrophils against C. albicans 
hyphae and yeast in vitro (143, 146, 150, 152). In summary, neutrophils are recruited to and 
actively interact with fungal cells of both Candida species, despite the nearly undetectable levels 
of inflammatory cytokine production in C. parapsilosis infection.  
2.2.6 Macrophages are recruited to infections of both Candida species.  
Although patrolling macrophages play an important role in initiation of inflammation 
through the production of cytokines and are essential for controlling invasive candidiasis, they 
are thought to play a redundant role in mucosal Candida infection (86, 142, 155, 157, 231, 280, 
281). Nevertheless, we observed a significant C. albicans-specific induction of ccl2 that 
suggested macrophages would be recruited only upon C. albicans infection. To our surprise, we 
found increased numbers of macrophages in the swimbladders of both C. parapsilosis-infected 
and C. albicans-infected fish (Fig. 2.8A-D; medians: Mock-infected:3 C.p.:6, C.a.:9).  
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Figure 2.8. Both C. albicans and C. parapsilosis elicit macrophage recruitment. 
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Figure 2.8 continued. Transgenic mpeg1:GAL4/UAS:nfsB-mCherry zebrafish (red 
macrophages) were infected and imaged at 24 hpi. (A-C) Representative images of zebrafish 
swimbladders injected with vehicle (A), C. parapsilosis (B) or C. albicans (C). Maximum 
projections, n slices: n=16 (A), n=13 (B, C), with (left) and without (right) single DIC z-slice, (D) 
Macrophages per fish in the swimbladder lumen. Data pooled from 7 independent experiments. 
(E) Macrophages per fish interacting with C. parapsilosis or C. albicans. (F) Percentage of 
interacting macrophages engaged in phagocytosis. (G) Number of macrophages interacting with 
fungi. Number of macrophages scored for Vehicle, C. parapsilosis and C. albicans, respectively: 
137, 135 and 367. Statistics as described in Materials & Methods: *, P<0.05, **, P<0.01, ***, 
P<0.001, ****, P<0.0001, n.s. not significant, P>0.05). Scale bars: (A-C) 150 µm.  
 
Patterns of macrophage interaction with Candida cells were remarkably similar to those 
of neutrophils. We found more macrophages interacting with the pathogen in C. albicans 
infections (median: 5 per fish) than in C. parapsilosis infections (median: 2 per fish) (Fig. 2.8E). 
As was the case for neutrophils, similar percentages (around 60%) of macrophages interacting 
with the two pathogens were engaged in phagocytosing them (Fig. 2.8F). Macrophages, like 
neutrophils, were found interacting with C. albicans hyphae more often than with yeast (Fig. 
2.8G). Thus, macrophages are recruited to infections of both Candida species and although 
they are found in lower numbers than neutrophils, they interact with and phagocytose both 
species. 
2.2.7 Functional neutrophils are required for protection from C. albicans but not C. 
parapsilosis infection.  
High levels of neutrophil engagement suggested to us that these cells play an important 
role in the immune response to both Candida species in the swimbladder model. We were 
interested to see if neutrophilic inflammation is protective, as in the murine oral infection models, 
or damaging, as in human vulvovaginal infection (140, 257). To block neutrophil function, we 
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employed the transgenic fish line, Tg(mpx:mCherry-2A-Rac2D57N) (D57N), a model of 
leukocyte adhesion deficiency in which neutrophils are present but defective in extravasation 
and phagocytosis (201, 282–284). In the low-dose swimbladder infection model, neutrophils in 
D57N zebrafish fail to migrate into the C. albicans-infected swimbladder and this makes the fish 
susceptible to invasive disease (142). When infected with higher doses of C. albicans, D57N 
zebrafish exhibited nearly 100% mortality by 4 dpi as compared to only 50% mortality in their 
wild-type (WT) siblings (Fig. 2.9A). Surprisingly, survival rates for D57N fish infected with C. 
parapsilosis were not significantly different from the nearly 100% survival found in their WT 
siblings, despite the lack of neutrophil recruitment that was expected in this fish line (Fig. 2.9A). 
C. albicans-infected D57N fish had more severe infections than their WT siblings, with extensive 
growth of filaments that often breached the swimbladder epithelium. 
We reasoned that inactivation of neutrophils could alter cytokine signaling through 
opposing mechanisms: greater damage to epithelial and other tissues could release damage-
associated molecular patterns and provoke higher expression of inflammatory cytokines; 
alternatively, the absence of neutrophils at the site of infection could eliminate their contribution 
to amplification of the inflammatory response (285). Surprisingly, we found that D57N fish had 
nearly identical levels of tnfa, and cxcl8 (Fig. 2.9B) as well as saa, il-10 and il-1b (Fig. 2.9C) 
expression as compared to their WT siblings when infected with C. albicans. Levels of these 
cytokines were also similar in both WT and D57N infections with C. parapsilosis. These data 
suggest that neutrophil inactivation does not have a strong overall net effect on inflammatory 
signaling. 
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Figure 2.9. Neutrophil defects impact immunity to C. albicans but not C. parapsilosis 
infection.   
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Figure 2.9 continued. (A) Tg(mpx:mCherry-2A-Rac2D57N) zebrafish (D57N) and their wild-
type (WT) siblings were infected at 4 dpf and monitored for four days. Survival curves are based 
on data pooled from 3 independent experiments. (B, C) qPCRs of cohorts of 10 fish, in 3 
independent experiments, performed as described for Fig. 2.2. The median log2 fold changes 
relative to vehicle-injected fish are plotted. Grey bars (WT), red bars (D57N mutant); dotted bars 
(C. parapsilosis-infected) and solid bars (C. albicans-infected) fish. Notations above individual 
bars indicate differences between Candida-infected and vehicle-injected groups. Notations 
above brackets indicate differences between WT and D57N fish. Statistics as described in 
Materials & Methods: *, P<0.05, **, P<0.01, ***, P<0.001, n.s. not significant, P>0.05.  
 
2.3 Discussion 
Candida albicans and Candida parapsilosis are opportunistic yeast pathogens that live 
as commensals of healthy people but breach epithelial barriers to cause serious illness in 
immunocompromised patients. To understand how fungi breach this barrier, it is important to 
study the interactions between Candida cells and host defenses at mucosal surfaces in the 
intact host. By modeling mucosal Candida infection in the transparent larval zebrafish, we were 
able to visualize interactions between host immune cells, epithelial cells and fungal pathogens 
in 4D in the live host. We discovered that mucosal infection by C. albicans, but not C. 
parapsilosis, caused significant mortality, activated NF-kB signaling, and evoked a strong local 
pro-inflammatory response. Despite the differential ability of the two species to activate 
inflammatory pathways, infections with both species stimulated recruitment of neutrophils and 
macrophages that actively attacked the fungi. Overall, our findings suggest that the contrasting 
immune responses to the two species of Candida in the swimbladder more closely resemble in 
vitro epithelial cell responses than in vitro mononuclear phagocyte responses, suggesting an 
important role for the epithelium in the overall inflammatory response. 
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The lack of C. parapsilosis virulence in the zebrafish is consistent with what has been 
seen in other infection models. This is the case for disseminated and mucosal disease in mice 
(50), as well as in vitro challenges with epithelial cells (135, 265, 286). Although C. parapsilosis 
is a common commensal fungus (43, 287), its virulence is usually associated with the hospital 
setting and it is thought that predisposing conditions such as epithelial damage or barrier breach 
by medical interventions lead to disseminated infection(38, 287). In zebrafish models of C. 
albicans infection, penetrating hyphae are closely associated with mortality and yeast-locked 
strains have limited virulence (74, 142, 229). Hyphal growth has also been clearly implicated in 
epithelial destruction in vitro and in mouse disease models (47, 62, 95, 288). Thus, while the 
reduced ability of C. parapsilosis to cause mortality in the absence of neutrophil function may be 
due to any number of differences between the two species, the lack of filamentous growth and 
expression of genes co-regulated with the hyphal switch (such as candidalysin) are likely to be 
major determinants of differential virulence (81, 289). 
Infection with C. albicans, but not with C. parapsilosis, elicited strong pro-inflammatory 
responses, as measured by whole-fish cytokine expression and local activation of NF-kB 
signaling and TNFα expression. This differential response is similar to what has been seen in 
epithelial cells in vitro, where many fungi activate NF-kB but only a challenge with C. albicans 
leads to further activation of inflammatory pathways and production of cytokines (135, 265, 
277). Our results contrast with what is seen in phagocytes, which respond strongly ex vivo to 
both Candida species by producing pro-inflammatory cytokines (165, 166).  One caveat to the 
work here, however, is that only single isolates of each species were tested in the zebrafish, 
and there are known isolate-specific differences in immune recognition and activation (289–
295). It is intriguing that, in spite of the presence of phagocytes in both C. albicans and C. 
parapsilosis swimbladder infections, the signaling response in vivo to these mucosal infections 
is more similar to the simplified Candida-human epithelium challenges than to the ex vivo 
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Candida-phagocyte challenges. C. parapsilosis supernatants have been shown to have an 
inhibitory effect on C. albicans-mediated invasion and damage to epithelial cells in co-culture 
with C. albicans and on virulence in swimbladder infection; this may explain the lack of immune 
signaling in response to C. parapsilosis in vivo seen here (296). Our results are consistent with 
the idea that epithelial cells have a prominent role in regulating the overall inflammatory 
response to Candida at mucosal surfaces, in addition to acting as a physical barrier and 
initiating immune responses (297–300). 
Using transgenic reporter zebrafish, we found differential patterns for activation of NF-kB 
and expression of TNFα in the swimbladder during C. albicans infection. NF-kB activation alone 
was seen in the epithelial layer surrounding the swimbladder, although both NF-kB activation 
and TNFα expression were observed in cells that were not part of the epithelial layer, including 
macrophages. This may mean that the activation of immune pathways results in different 
responses in different cell types; for example, in epithelial cells in vitro, NF-kB is activated but 
doesn’t lead to cytokine production (301). Alternatively, these differences may result from the 
different receptors mediating C. albicans recognition in epithelial cells and phagocytes (18, 302, 
303) or from cross-talk among cell types as the infection progresses (171, 173). It is unlikely that 
this differential expression pattern is due to reporter-line differences, as many cell types, 
including epithelial cells and innate immune cells, are capable of activating NF-kB and 
expressing TNFα in these fish lines (195, 196, 230, 304–308). Nonetheless, because no 
reporter gene completely recapitulates the activity of the native locus, these results should be 
extended through experiments using complementary reporters and reagents to test native 
expression patterns. Work with transgenic reporters for other signaling components such as IL-1 
(197) could contribute to deciphering this puzzle. 
Phagocyte recruitment and activation is often associated with proinflammatory cytokine 
and chemokine production, but we observed recruitment and active engagement of both 
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macrophages and neutrophils without significant cytokine elicitation in C. parapsilosis infection 
(309–311). Several non-cytokine chemoattractants such as reactive oxygen species, lipids and 
secreted fungal molecules are associated with fungal infection in mouse and zebrafish infection 
models (140, 210, 221, 252, 312–316). Thus, phagocyte recruitment in C. parapsilosis infection 
may be the result of non-cytokine signals, underlining the potential importance of these 
alternative chemoattractants.  
Although C. albicans and C. parapsilosis are two of the most common causes of 
systemic fungal infections, the risk factors for the two species differ. In humans, neutropenia is a 
major risk factor for disseminated C. albicans infection but only a small percentage of C. 
parapsilosis cases involve neutrophil depletion (43, 287). Likewise, immunosuppressed mice 
are highly susceptible to C. albicans but not C. parapsilosis disseminated infection (317, 318). 
These differences are reflected in the experiments presented here, which show that neutrophils 
are not required for immunity to C. parapsilosis infection, in contrast to the earlier finding that 
neutrophils are essential for protection from C. albicans mucosal infection (142). This difference 
may indicate that neutrophils are important in controlling hyphal growth of C. albicans, but 
redundant for managing C. parapsilosis, whose yeast-only morphology may be contained by the 
remaining phagocytes (55, 142). Indeed, in the zebrafish, neutrophils and macrophages 
interacted with both hyphae and yeast of C. albicans, consistent with results from in vitro 
neutrophil and macrophage challenges (148, 168, 174). C. parapsilosis yeast and 
pseudohyphae are readily engulfed and killed by phagocytes in vitro, while engulfment of C. 
albicans requires longer times that vary with hyphal size and orientation (63, 147, 148, 180, 319, 
320). Although macrophages are known to protect from disseminated candidiasis, our recent 
work and that of others indicates macrophages are redundant with respect to protection from 
mucosal C. albicans infection (142, 155, 157). In our higher-dose model, macrophages were 
recruited in significant numbers, activated NF-kB, expressed TNFα, and interacted with both 
Candida species. It is intriguing that macrophages upregulate TNFα upon C. albicans but not C. 
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parapsilosis infection, suggesting that epithelial-macrophage crosstalk or damage-induced 
signaling regulates cytokine production. 
Overall, our work points to the unique characteristics of the zebrafish model (ease of live 
imaging, availability of transgenic lines) for discovery of previously unattainable information 
about host-pathogen interactions in vivo. Our comparison of host responses to two Candida 
species indicates that, unlike C. albicans, C. parapsilosis does not cause strong inflammatory 
responses or invasive disease at this mucosal site. We found a disconnect between 
inflammatory responses and phagocyte recruitment/activity that emphasizes the need for further 
study of signaling molecules that act on innate immune cells. Finally, imaging of single-cell 
patterns of gene activation paints a more complex picture of cell type-specific signaling during 
mucosal candidiasis. In sum, the tissue-specific aspects of host response against Candida 
species is an important and understudied aspect of disease that will benefit from future studies 
in zebrafish, mammalian hosts and more complex in vitro challenge systems with more cell 
types. 
2.4 Materials and Methods 
2.4.1 Candida strains and growth conditions  
Candida strains used in this study are listed in Table 2.1. Candida was maintained in YPD 
media (DIFCO; 20 g/L peptone, 10 g/L yeast extract) containing 2% glucose and glycerol (30%) 
at -80 C, then grown on YPD agar plates at 30°C. Single colonies were picked to 5 ml YPD 
liquid and grown at 30°C overnight on a rotator wheel (New Brunswick Scientific). Prior to 
injection into zebrafish swimbladders, Candida cultures were washed 3x in phosphate buffered 
saline (PBS), counted on a hemocytometer and resuspended in 5% polyvinylpyrrolidone (PVP) 
(Sigma-Aldrich) in PBS at a concentration of 5 x 107 cells/ml.  
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Table 2.1 Candida strains 
Strain Source/Reference 
C. albicans SC5314 Caf2.1-dTom-NATr 
 R. L. Gratacap, J. F. Rawls, and R. T. 
Wheeler, Dis. Model. Mech. 6: 1260–70, 
2013, doi: 10.1242/dmm.012039 
C. albicans WT-GFP (SC5314 (Peno1-
yEGFP3-NAT)) 
R. T. Wheeler, D. Kombe, S. D. Agarwala, 
and G. R. Fink, PLoS Pathog. 4: 1–12, 2008, 
doi: 10.1371/journal.ppat.1000227 
C. albicans SC5314 Caf2:FR   
A. C. Bergeron, B. G. Seman, J. H. 
Hammond, L. S. Archambault, D. A. Hogan, 
and R. T. Wheeler, Infect. Immun., 2017, 
doi:10.1128/IAI.00475-17 
C. parapsilosis clinical isolate 4175 (A010) 
CpURA3/CpURA3 ENO1/ENO1::GFP-NAT1 S. Gonia, B. Larson, and C. A. Gale, Yeast, 
33(2): 63–9, 2016, doi: 10.1002/yea.3141 C. parapsilosis clinical isolate 4175 (A010) CpURA3/CpURA3 ENO1-mCherry-
NAT1/ENO1 
 
2.4.2 Animal care and maintenance  
Adult zebrafish were held in recirculating systems (Aquatic Habitats) at the University of 
Maine Zebrafish Facility, under a 14/10-hour light/dark cycle, and water temperature of 28°C; 
they were fed with Hikari Micro Pellets (HK40, Pentair Aquatic Ecosystems). Zebrafish strains 
used in this study are described in Table 2.2. Spawned eggs were collected and reared to 4 
days post fertilization (dpf) at 33°C in E3 (5 mM sodium chloride, 0.174 mM potassium chloride, 
0.33 mM calcium chloride, 0.332 mM magnesium sulfate, 2 mM HEPES in Nanopure water, pH 
7) supplemented with 0.02 mg/ml of 1-phenyl-2-thiourea (PTU) (Sigma-Aldrich, St. Louis, MO) 
to prevent pigmentation. A temperature of 33ºC was chosen as an intermediate temperature 
between the typical lab environment for zebrafish (28ºC) and temperatures found in mouse and 
human (30ºC on skin to 37ºC core, (321, 322)). We note that, although temperature is a cue 
used by C. albicans to control morphology, other in vivo signals drive strong hyphal growth in 
the zebrafish, even at 28ºC (323).  
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When using D57N zebrafish, heterozygous transgenic fish were crossed with opposite 
sex AB fish and progeny were sorted for the presence of mCherry in neutrophils (D57N) or its 
absence (WT siblings). To obtain heterozygous offspring with consistent fluorescence levels, 
Tg(NF-kB:EGFP) or TgBAC(tnfa:GFP) fish were crossed with opposite sex AB fish and 
embryos were screened on a Zeiss Axiovision VivaTome microscope (Carl Zeiss Microscopy, 
LLC) for basal GFP expression before injecting.  mpeg1:GAL4/UAS:nfsB-mCherry embryos 
were obtained by crossing Tg(mpeg1:GAL4):gl24Tg (199) with opposite sex Tg(UAS-E1b:NTR-
mCherry):c264Tg fish (198). 
2.4.3 Zebrafish infections. Zebrafish infections were carried out by glass needle 
injection into the swimbladder as previously described (232). Briefly, 4 dpf zebrafish were 
anaesthetized with Tris-buffered tricaine methane sulfonate (160 µg/ml; Tricaine; Western 
Chemicals, Inc., Ferndale, WA) and injected with 4 nL PVP alone or PVP containing 5 x 107 
Table 2.2 Zebrafish lines  
Line Source/Reference 
Wildtype AB Zebrafish International Resource Center (ZIRC) 
Tg(mpx:GFP)i114Tg S. Renshaw and C. Loynes, Blood 108:3976–3978, 2006, doi: 10.1182/blood-2006-05-024075 
Tg(mpx:mCherry) 
uwm7Tg 
S. K. Yoo, Q. Deng, P. J. Cavnar, Y. I. Wu, K. M. Hahn, 
 and A. Huttenlocher, Dev. Cell 18: 226–236, 2010,  
doi: 10.1016/j.devcel.2009.11.015 
Tg(mpeg1:GAL4)gl24Tg 
F. Ellett, L. Pase, J. W. Hayman, A. Andrianopoulos, and 
G. J. Lieschke, Blood, 117:e49-56, 2011, 
doi: 10.1182/blood-2010-10-314120. 
Tg(UAS-E1b:NTR- 
mCherry)c264Tg 
M. G. Goll, R. Anderson, D. Y. R. Stainier, A. C. Spradling, 
and M. E. Halpern, Genetics, 182: 747–755, 2009,  
doi: 10.1534/genetics.109.102079 
Tg(mpeg1:dTomato) A. J. Pagan et al., Cell Host Microbe, 18: 15–26, 2015, doi: 10.1016/j.chom.2015.06.008 
TgBAC(tnfa:GFP: 
pd1028Tg 
L. Marjoram et al., Proc. Natl. Acad. Sci., 112: 201424089, 
2015, doi: 10.1073/pnas.1424089112 
Tg(6xHsa.NFKBN:EGFP) 
nc1Tg 
M. Kanther et al., Gastroenterology, 141: 197–207, 2011, 
doi: 10.1053/j.gastro.2011.03.042 
Tg(mpx:mCherry,rac2_ 
D57N)zf307Tg 
Q. Deng, S. K. Yoo, P. J. Cavnar, J. M. Green, and 
A. Huttenlocher, Dev. Cell, 21: 735–45, 2011,  
doi: 10.1016/j.devcel.2011.07.013 
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yeast cells/ml of C. albicans or C. parapsilosis. Infected fish were placed in individual wells of a 
96-well glass-bottom imaging dish (Greiner Bio-One, Monroe, NC) and screened for inoculum of 
50-100 yeast on a Zeiss Axiovision VivaTome microscope. For survival curves, injected fish that 
passed screening were held for 4 days post-injection and monitored daily for survival. 
2.4.4 Fluorescence microscopy. For imaging, fish were anaesthetized with Tricaine 
then immobilized in 0.5% low-melting-point agarose (Lonza, Switzerland) in E3 containing 
Tricaine and arranged in a 96-well glass-bottom imaging plate. Images were made on an 
Olympus IX-81 inverted microscope with an FV-1000 laser scanning confocal system (Olympus, 
Waltham, MA), using a 20x/0.7 NA or 10x/0.4 NA objective lens. EGFP, dTomato/mCherry, and 
infra-red fluorescent proteins were detected by laser/optical filters for excitation/emission at 488 
nm/505 to 525 nm, 543 nm/560 to 620 nm, and 635 nm/655 to 755 nm, respectively. Images 
were collected with Fluoview (Olympus) software.  
2.4.5 Dissected swimbladders. After live imaging, chosen zebrafish were euthanized 
with Tricaine overdose at 25-27 hpi and swimbladders were removed with fine forceps as 
described (232). Swimbladders were transferred to 0.4% low melt agarose in PBS on a 25 x 75 
x 1.0 mm microscope slide and covered with an 18 x 18 mm, no. 1.5 cover slip. Pre-applied 
dabs of high vacuum grease (Dow Corning, Midland, MI) at the corners of the cover slip 
prevented crushing and deflation of the swimbladder. The slides were imaged within 15 minutes 
on an Olympus IX-81 inverted confocal microscope using a 20x/0.7 NA objective lens as 
described above.  
2.4.6 Quantitative real-time PCR. Total RNA was extracted by homogenizing groups of 
10-14 whole, euthanized larvae in TRIzol (Invitrogen, Carlsbad, CA). Cleanup was achieved 
using an RNeasy kit (Qiagen, Germantown, MD) according to the manufacturer’s protocol with 
the addition of an on-column DNase step (New England BioLabs, Ipswich, MA). RNA was 
eluted in 20 µL of nuclease-free water and stored at -80°C. cDNA was synthesized from 500 ng 
of RNA per sample using iScript reverse transcription (RT) supermix for RT-qPCR (Bio-Rad, 
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Hercules, CA) and a no-RT reaction was performed for each sample. qPCR was carried out 
using SsoAdvanced Universal SYBR Green Supermix (Bio-Rad), in 10 µL reactions, using 1µL 
cDNA per reaction and 0.3 µM primer concentration, on a CFX96 thermocycler (Bio-Rad). 
Threshold cycles (Ct) and dissociation curve were analyzed with Bio-Rad CFX Manager 
software. The change in gene expression was normalized to gapdh (ΔCt) then compared to 
vehicle-injected controls (ΔΔCt) using the 2-∆∆Ct method (324). Primers (Integrated DNA 
Technologies) are listed in Table 2.3. 
 
2.4.7 Image analysis. The percent of the swimbladder covered by Candida at 24hpi was 
determined using Fiji software (ImageJ environment,(325)) applied to maximum projection 
images from stacks of 15-25 z-slices. Images were taken with identical acquisition settings to 
ensure comparability. The swimbladder area was delineated and % coverage of Candida 
fluorescence above a set threshold (corresponding to background fluorescence) was calculated. 
Images of the swimbladder area of Tg(NF-kB:EGFP) and TgBAC(tnfa:GFP) fish were analyzed 
using Fiji software. Images covered the swimbladder from midline to skin in 5 µm z-slices. The 
Table 2.3 qPCR primer information 
Gene Sequence (5’-3’) Reference  
ccl2 Fw, GTCTGGTGCTCTTCGCTTTC Rv, TGCAGAGAAGATGCGTCGTA 
C. J. Cambier et al., Nature: 505:218–22, 2014, 
doi:10.1038/nature12799 
cxcl8 Fw, TGCATTGAAACAGAAAGCCGACG Rv, ATCTCCTGTCCAGTTGTCATCAAGG 
A. C. Bergeron, B. G. Seman, J. H. Hammond, L. 
S. Archambault, D. A. Hogan, and R. T. Wheeler,  
Infect. Immun., p. IAI.00475-17, 2017, 
doi:10.1128/IAI.00475-17 il6 
Fw, GGACGTGAAGACACTCAGAGACG 
Rv, AAGGTTTGAGGAGAGGAGTGCTG 
il10 Fw, ATTTGTGGAGGGCTTTCCTT Rv, AGAGCTGTTGGCAGAATGGT 
F. J. Roca et al., J. Immunol., 181: 5071–5081, 
2008, doi:10.4049/jimmunol.181.7.5071 
saa Fw, CGGGGTCCTGGGGGCTATTG Rv, GTTGGGGTCTCCGCCGTTTC 
B. Lin et al., Mol. Immunol., 44: 295–301, 2007, 
doi: 10.1016/J.MOLIMM.2006.03.001 
tnfa Fw, CGCATTTCACAAGCGAATTT Rv, CTGGTCCTGGTCATCTCTCC 
R. L. Gratacap, J. F. Rawls, and R. T. Wheeler, 
Dis. Model. Mech. 6: 1260–70, 2013, 
doi:10.1242/dmm.012039 
gapdh Fw, TGGGCCCATGAAAGGAAT Rv, ACCAGCGTCAAAGATGGATG 
C. J. Mattingly, T. H. Hampton, K. M. Brothers, N. 
E. Griffin, and A. Planchart, Environ. Health 
Perspect., 117: 981–7, 2009, 
doi:10.1289/ehp.0900555 
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number of slices per image ranged from 12 to 22, depending on the size of the fish. Time lapse 
images were processed in Fiji using descriptor-based registration (326). Neutrophils and 
macrophages were outlined and counted in Fluoview (Olympus), from images taken at 24 hpi. 
2.4.8 Statistical analysis. Statistical analyses were carried out using GraphPad Prism 7 
software (GraphPad Software, Inc., LaJolla, CA). All significant differences are indicated in the 
figures; *, **, ***, and **** indicate p values of <0.05, <0.01, <0.001, and <0.0001, respectively. 
When data failed to pass the D'Agostino & Pearson test for normal distribution of data, or when 
the number of samples was too small to determine normality, non-parametric statistics were 
used (Fig. 2.1B, Fig. 2.2, Fig. 2.3D, Fig. 2.4A, Fig. 2.7H, Fig. 2.8D-E, Fig. 2.9B-C). Kaplan-Meier 
survival curves were subjected to a log-rank (Mantel-Cox) test then Bonferroni correction was 
used to determine statistical difference between pairs of treatments (Fig. 2.1G, Fig. 2.9A). NF-
kB activation, TNFα expression, macrophage recruitment, and qPCR results were analyzed 
using the Kruskal-Wallis test by ranks and Dunn’s test for multiple comparisons (Fig. 2.2, Fig. 
2.3D, Fig. 2.4A, Fig. 2.8D, Fig. 2.9B). Neutrophil recruitment data were normally distributed so 
an ANOVA with Tukey’s test for multiple comparison’s was used (Fig. 2.7D). To compare 
Candida burden and phagocyte interactions, we used the Mann-Whitney test (Fig. 2.1B, Fig. 
2.7H, Fig. 2.8E). The Fisher’s Exact test was used to compare the neutrophils and 
macrophages engaged in phagocytosis of the two Candida species (Fig. 2.7I, Fig. 2.8F). Paired 
t-tests were used to compare interactions of phagocytes with C. albicans hyphae and yeast (Fig. 
2.7J, Fig. 2.8G). 
2.4.9 Ethics statement. All zebrafish studies were carried out in accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the National 
Institutes of Health (327). All animals were treated in a humane manner and euthanized with 
Tricaine overdose according to guidelines of the University of Maine IACUC as detailed in 
protocol number A2015-11-03.  
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CHAPTER 3 
 
CANDIDA PARAPSILOSIS PROTECTS ZEBRAFISH FROM INFECTION  
BY CANDIDA ALBICANS 
 
3.1 Introduction 
 
Candida species cause invasive candidiasis in premature infants. The route of entry into 
the bloodstream is thought to be through immature or damaged epithelial barriers (35, 328, 
329). Deadly illnesses of the gastrointestinal tract of premature infants such as necrotizing 
enterocolitis and spontaneous intestinal perforation are correlated with invasive candidiasis 
(330–332). While both species are isolated from blood stream infections in neonates, C. 
parapsilosis has less ability than C. albicans to damage and invade epithelial cells in culture 
(139, 265).  
Since the two Candida species colonize the gut in neonates, we hypothesized that they 
might interact in ways that could alter the damage to the mucosal epithelium. Although it might 
be expected that the mixed infection would lead to synergistic or additive damage, researchers 
in the lab of Dr. Cheryl Gale found that C. parapsilosis protected premature intestinal epithelial 
cells (pIECs) from invasion and damage by C. albicans (296). The protection was found to 
depend on both a physical interaction that was correlated with the adhesiveness of C. 
parapsilosis for C.albicans hyphae and for epithelial cells, but also on a substance secreted by 
C. parapsilosis. I collaborated with the Gale lab to determine whether this phenomenon also 
occurs in vivo. In the zebrafish swimbladder mucosal infection model, co-injection of C. albicans 
yeast with cell-free fractions from C. parapsilosis cultures decreased infection parameters and 
mortality. These results suggest that non-invasive commensals could be used to interfere with 
virulence of pathogens and could provide a non-pharmacological method of protecting infants 
from invasive disease. 
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3.2 Results and Discussion 
To test the protective ability of C. parapsilosis in vivo, zebrafish were infected in the 
swimbladder with C. albicans yeast suspended in C. parapsilosis supernatant, C. albicans 
supernatant, or unconditioned medium. This infection model recapitulates a number of aspects 
of in vitro C. albicans–epithelial interactions, permits mucosal infection in the context of a 
vertebrate immune system and allows for high inoculum doses that cause infection without 
immunosuppression. Therefore, this optically transparent disease model is more complex than 
in vitro challenge of epithelial cells but is not as complex as the mouse intestinal colonization 
model, which is reliant on antibiotic treatment for colonization and requires both physical 
disturbance and immunosuppression to yield lethal infection (333). Cell-free fractions of C. 
albicans and C. parapsilosis cultures, as well as medium alone, had no effect on zebrafish 
viability. When C. albicans was suspended in C. parapsilosis supernatant, mortality was 
significantly reduced (Figure 3.1B) as compared to C. albicans suspended in its own 
supernatant or fresh unconditioned medium. The effect of C. parapsilosis cells along with cell-
free fractions on zebrafish viability could not be tested due to the number of yeast in the mixed 
inoculum being beyond the physical constraints of microinjection into the zebrafish swimbladder. 
Deflation of the swimbladder and breaching of the swimbladder epithelium by hyphae 
are visual hallmarks of C. albicans infection in zebrafish (232). Nearly half of the fish infected 
with C. albicans suspended in C. albicans supernatant experienced swimbladder deflation at 24 
hpi. By contrast, significantly fewer fish had deflated swimbladders when C. albicans was 
suspended in C. parapsilosis supernatants (Figure 3.1C). In addition, there was a trend toward 
more breaching of the swimbladder epithelium by C. albicans hyphae with addition of C. 
albicans supernatant than for C. parapsilosis supernatant or control media, although this 
difference did not reach statistical significance (Figure 3.1D). Together, these results indicate 
that C. parapsilosis supernatants protect zebrafish from the effects of C. albicans infection. 
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Figure 3.1. Candida parapsilosis cell-free culture fraction protects zebrafish from 
infection by Candida albicans. (A) Schematic of infection model. The larval zebrafish 
swimbladder offers a transparent vertebrate mucosal infection model that is amenable to non-
invasive imaging of both the host and the pathogen. (B–D) Zebrafish at 4 days post-fertilization 
with inflated swimbladders were infected in their swimbladders by glass needle injection with C. 
albicans yeast cells (C.a.) suspended in control (H4) media or in supernatants from C. 
parapsilosis (C.p. Supt) or C. albicans (C.a. Supt.) cultures. (B) Relative survival of fish infected 
with C. albicans with or without Candida supernatants. All C. albicans-infected fish cohorts are 
significantly different from their respective controls. C. parapsilosis supernatants significantly 
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Figure 3.1 continued. reduce the mortality of a C. albicans infection (denoted by γ). Matching 
Greek letters label individual comparisons: α, p < 0.01; β, p < 0.0001; γ, p < 0.05. Survival data 
are pooled from two independent experiments, n = 20 per group. All pair-wise comparisons 
were made with the Mantel–Cox test. (C,D) Fish from the experiment in (B) were viewed by 
fluorescence microscopy at 24 h post-infection and scored for two indicators of infection, 
swimbladder deflation [(C) **p < 0.01] and breaching of epithelial barrier (D). Data were pooled 
from two independent experiments and analyzed by Fisher’s exact test with Bonferroni 
correction (Control media, n = 22, C.a. supernatant, n = 21, C.p. supernatant, n = 22). 
 
The inhibitory effect of C. parapsilosis on C. albicans virulence supports the idea that 
factors contributing to the commensal vs. pathogenic nature of microbes are modulated by other 
microbes. It is notable that the zebrafish swimbladder is not sterile, so the conservation of a 
protective effect in this mucosal model suggests that the in vitro results have relevance in vivo. 
The effects on C. albicans virulence should be confirmed in further animal studies.  
While the in vitro work in this study pointed to two mechanisms of inhibition, by C. 
parapsilosis cells and by cell-free supernatants, it is interesting to note that cell-free 
supernatants alone appeared to reduce the ability (although not significantly) of C. albicans to 
penetrate the zebrafish swimbladder epithelial layer (Figure 3.1D). 
C. parapsilosis is a pathogen that is particularly associated with infants in neonatal 
intensive care (43, 44). Thus, it is somewhat surprising that it has a role in protection from C. 
albicans-induced damage to epithelial cells and mortality in zebrafish. These results lend 
support to the idea that C. parapsilosis enters the host through sites other than mucosal tissues 
such as intravascular catheters. However, they don’t rule out the possibility of C. parapsilosis 
entry into the blood stream through epithelial damage caused by other microbes, including C. 
albicans. 
  
  71 
3.3 Materials and Methods 
Fungal growth conditions and Preparation of cell and cell-Free Fractions for assays 
Yeast strains (see Table 2.1) were propagated and maintained as described previously (334). 
Strains were recovered from 15% glycerol stocks stored at −80°C by plating onto Yeast 
Peptone Dextrose agar and incubating at 30°C overnight. Individual colonies were then 
suspended and grown in synthetic dextrose complete medium containing 2% glucose at 30°C 
overnight prior to assays being performed. Cell concentrations were determined microscopically 
using a hemocytometer. To obtain cell-free culture fractions, yeast cells were grown as 
described above, sub-cultured into H4 tissue culture medium at a concentration of 2 × 106 
cells/mL and grown at 30°C for 12 h. Yeast cells were pelleted by centrifugation at 13,000 rpm 
for 3 min. The supernatants were removed carefully using a pipet, so as not to disturb the cell 
pellet. Supernatants were visualized microscopically using 60× magnification in multiple random 
fields to ensure that no yeast cells were present. 
Zebrafish growth, Maintenance, and infection All animal studies were carried out in 
accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals 
of the National Institutes of Health. All animals were treated in a humane manner according to 
guidelines of the University of Maine IACUC as detailed in protocol number A2015-11-03. The 
UMaine IACUC/Ethics Committee approved this protocol. Animals were euthanized by tricaine 
overdose. 
Infected animals were monitored twice daily for signs of infection and morbid animals 
were euthanized. Wild-type AB zebrafish were maintained as described previously (232). 
Zebrafish larvae were grown in E3 medium (5.0 mM NaCl, 0.17 mM KCl, 0.33 mMCaCl, 0.33 
mM MgSO4, 2 mM HEPES, pH 7) plus 0.3 μg/mL methylene blue for the first 6 h post-
fertilization, then switched to E3 supplemented with 10 μg/mL 1-phenyl-2-thiourea to suppress 
pigmentation. The C. albicans CAF2.1-dTom-NATr strain was used for all experiments in 
zebrafish and was grown and prepared for infections as described previously (64, 230). 
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Overnight cultures were washed three times in calcium- and magnesium-free PBS and yeast 
cell concentrations were determined microscopically using a hemocytometer. Cell suspensions 
were adjusted to a concentration of 5 × 107 cells/mL in 5% polyvinylpirrolidone dissolved inH4 
media alone or fungal culture supernatants. Zebrafish larvae were infected with yeast by 
injection into the swimbladder at 4 days post-fertilization (dpf) as previously described (232). 
Infected fish were individually screened at 2 h post-infection (hpi) on a Zeiss Axiovision 
Vivatome microscope. Mock-infected and infected fish were divided randomly into two cohorts. 
One cohort of 10 fish was held for 4 days, with counting and removal of deceased fish each day. 
The second cohort of fish was rescreened at 24 hpi and infection parameters (swimbladder 
deflation and epithelial breaching) were recorded. Statistical analysis was performed on 
GraphPad Prism version 7.00 for Mac (GraphPad Software, La Jolla, CA, USA, 
www.graphpad.com). Survival curves were analyzed using a log-rank (Mantel–Cox) test. 
Fisher’s exact test, with Bonferroni correction for multiple tests, was used to detect differences 
in infection parameters among groups. 
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CHAPTER 4 
CONCLUSIONS AND FUTURE DIRECTIONS 
In this study, we explored interactions between fungal and host cells at a mucosal site 
using intravital imaging of the zebrafish swimbladder. This work represents a first in vivo look at 
C. parapsilosis interactions with host cells and has led to the discovery of unexpected host 
responses. We found a disconnect between host cell inflammatory cytokine signaling, which 
occurs in C. albicans but not C. parapsilosis infection, and phagocyte engagement with the 
pathogen, which we saw with either Candida species. Detailed, single-cell analysis of time-lapse 
images indicated that the signaling of epithelial cells and phagocytes differs, confirming that 
these cell types have different roles in communicating information about the infection. In 
experiments that complemented in vitro work by the Cheryl Gale lab, we found that C. 
parapsilosis secreted substance(s) led to a reduction in mortality and signs disease caused by 
C. albicans. Our results emphasize the value of visualizing host-pathogen interactions at the 
cellular level in the live zebrafish host.  
4.1 Host Responses to C. parapsilosis and C. albicans 
When they encounter C. albicans or C. parapsilosis in vitro, phagocytes (PBMCs) 
respond to either species by producing pro-inflammatory cytokines. However, in vitro challenge 
of epithelial cells with these two fungal species results in significant production of cytokines only 
in response to C. albicans. Because epithelial cells and patrolling phagocytes both encounter 
the fungus in the mucosal environment of the zebrafish swimbladder, we expected a pro-
inflammatory response to C. albicans, but it was difficult to predict the overall response to C. 
parapsilosis.  
As expected, we found a whole-fish pro-inflammatory response, epithelial cell activation 
of NF-kB, and macrophage expression of TNFa in response to C. albicans. However, none of 
these responses occurred in C. parapsilosis infection. This result was particularly surprising in 
light of the fact that macrophages and neutrophils were attracted to the swimbladders of C. 
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parapsilosis-infected fish and interacted with the fungus there. Because these responses match 
those of epithelial cells in vitro, our results support the notion that epithelial cell signaling drives 
the overall response at mucosal surfaces (171, 173, 335). However, we have yet to provide 
mechanistic explanations for our observations.  
Several possible mechanisms could account for differences in host responses to these 
Candida species. First, C. albicans and C. parapsilosis yeast have different cell wall 
compositions (57, 336, 337). This may lead to differential sensing of these two pathogens by 
epithelial and/or immune cell PRRs and thus differential activation of pro-inflammatory 
pathways. Second, morphology plays a role in sensing of fungal pathogens. The yeast to hyphal 
switch is accompanied by changes in gene expression, many of which are not strictly related to 
morphology. Some gene-expression changes lead to differences in cell wall components, 
complicating explanations that rely on the different morphologies to explain differences in 
virulence. Lastly, apart from potentially being sensed differently by host cells through PRRs or 
simply on the basis of size (150), hyphae are capable of damaging epithelial cells through direct 
penetration and by production of the toxin, candidalysin. Thus, sensing of hypha-related 
damage could account for the difference in responses to C. albicans and C. parapsilosis.  
In order to test the first hypothesis –differences in cell wall components lead to 
differential sensing by host cells – we have carried out preliminary experiments comparing host 
responses to a yeast-locked strain of C. albicans (NRG1OEX-iRFP-NATR) and to C. parapsilosis. 
C. albicans:NRG1 caused no mortality in the zebrafish and recruited a similar number of 
neutrophils as mock-infection. Cytokine levels in NRG1-infected fish were similar to C. 
parapsilosis-infected and mock-infected fish and much lower than in WT C. albicans infection 
(Archambault & Wheeler, unpublished). Since host responses to C. parapsilosis and C. albicans 
in yeast form were similar, the results seem to indicate that it is something about hyphae that 
alerts the host and causes a pro-inflammatory response. However, it is not possible to 
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determine whether the differences we see are because hyphae are sensed differently or 
because of another unknown characteristic of hyphae. 
Evidence from epithelial cells in culture supports the idea that damage sensing plays a 
role in inflammatory responses. Epithelial cells activate pro-inflammatory signaling pathways 
and produce cytokines in response to Candida species that are capable of growing as true 
hyphae and that cause damage but not to C. parapsilosis and other non-hyphal, non-damaging 
species (135). In addition to cytokine expression, DAMPs from damaged epithelial cells may 
serve to recruit and activate phagocytes. ROS can serve as a DAMP and ROS is important for 
recruitment of phagocytes to C. albicans infection of the zebrafish hindbrain (210). Damage also 
initiates host cell eicosanoid signaling that is important for early recruitment of neutrophils (338).  
Two experiments could help to dissect the contributions of PAMP detection and damage 
detection to the pro-inflammatory responses we see in C. albicans infection in the swimbladder. 
Previous work in our lab has shown that a Candidalysin mutant strain ( D/Dece1) caused less 
damage to the swimbladder epithelium and recruited fewer neutrophils than WT C. albicans 
(81). Measuring cytokines in  D/Dece1-infected fish by qPCR could help determine the 
contribution of pathogen sensing by PAMPs (which should be similar in the WT and mutant 
infection) and damage (which is lower in the mutant infection) to the inflammatory response to 
C. albicans. Further information about the role of damage signaling could be ascertained by 
treating C. parapsilosis-infected and NRG-1-infected fish with exogenous Candidalysin peptide 
to cause damage to epithelial cells while maintaining the PAMP environment of the yeast form. 
If damage signaling is driving inflammatory responses, we should see increased cytokine 
expression in these infections. 
4.2 C. parapsilosis-Host Interactions 
Many pathogens manipulate host inflammatory responses to avoid detection, 
phagocytosis and killing, and to aid in dissemination (339). C. parapsilosis is known to secrete 
  76 
lipid mediators which could suppress host immune responses(340). In collaborative work with 
the Gale lab, we showed that a C. parapsilosis-secreted substance protects zebrafish with 
swimbladder infections and epithelial cells in culture from damage by C. albicans (296). Pro-
inflammatory cytokines such as TNFa cause vasodilation, swelling and loosening of the 
intracellular matrix, which facilitates extravasation of phagocytes and their ability to crawl 
through tissues to the site of infection (278). These effects might also allow C. albicans hyphae 
to penetrate and damage tissues more easily. If a C. parapsilosis-secreted substance has a 
suppressing effect on inflammatory signaling, it could help to explain how it protects from C. 
albicans’ damage and also explain the negligible cytokine signaling we saw in response to C. 
parapsilosis infection. Further work to determine the nature of the secreted substance could 
lead to a better understanding of the nature of this protection. Separation and testing of lipid and 
peptide fractions of C. parapsilosis supernatants would be a logical next step.  
4.3 Conclusions 
In this study we chose to investigate mucosal disease caused by two fungal species, the 
common commensal/opportunistic pathogen, C. albicans, and the understudied, but clinically 
relevant, C. parapsilosis. Intravital imaging of the transparent zebrafish model revealed the 
intimate details of host-pathogen interactions at the cellular level. Interesting and unexpected 
details of signaling by epithelial cells and phagocytes were revealed in transgenic reported fish. 
Some of our results stand in direct contrast to those obtained when single cell types encounter 
these fungi in vitro. Although much remains to be discovered concerning pathogen virulence 
traits and host responses in mucosal candidiasis, our study showcases the value of in vivo 
observations of host-pathogen interactions and provides important insights into the behavior 
and signaling of cells at mucosal surfaces. 
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